Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
18 "Lymph nodes"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Articles
Gastrointestinal cancer
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim
Cancer Res Treat. 2023;55(3):956-968.   Published online February 27, 2023
DOI: https://doi.org/10.4143/crt.2022.409
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The benefit of adjuvant chemotherapy following curative-intent surgery in pancreatic ductal adenocarcinoma (PDAC) patients who had received neoadjuvant FOLFIRINOX is unclear. This study aimed to assess the survival benefit of adjuvant chemotherapy in this patient population.
Materials and Methods
This retrospective study included 218 patients with localized non-metastatic PDAC who received neoadjuvant FOLFIRINOX and underwent curative-intent surgery (R0 or R1) between January 2017 and December 2020. The association of adjuvant chemotherapy with disease-free survival (DFS) and overall survival (OS) was evaluated in overall patients and in the propensity score matched (PSM) cohort. Subgroup analysis was conducted according to the pathology-proven lymph node status.
Results
Adjuvant chemotherapy was administered to 149 patients (68.3%). In the overall cohort, the adjuvant chemotherapy group had significantly improved DFS and OS compared to the observation group (DFS: median, 13.8 months [95% confidence interval (CI), 11.0 to 19.1] vs. 8.2 months [95% CI, 6.5 to 12.0]; p < 0.001; and OS: median, 38.0 months [95% CI, 32.2 to not assessable] vs. 25.7 months [95% CI, 18.3 to not assessable]; p=0.005). In the PSM cohort of 57 matched pairs of patients, DFS and OS were better in the adjuvant chemotherapy group than in the observation group (p < 0.001 and p=0.038, respectively). In the multivariate analysis, adjuvant chemotherapy was a significant favorable prognostic factor (vs. observation; DFS: hazard ratio [HR], 0.51 [95% CI, 0.36 to 0.71; p < 0.001]; OS: HR, 0.45 [95% CI, 0.29 to 0.71; p < 0.001]).
Conclusion
Among PDAC patients who underwent surgery following neoadjuvant FOLFIRINOX, adjuvant chemotherapy may be associated with improved survival. Randomized studies should be conducted to validate this finding.

Citations

Citations to this article as recorded by  
  • The survival effect of neoadjuvant therapy and neoadjuvant plus adjuvant therapy on pancreatic ductal adenocarcinoma patients with different TNM stages: a propensity score matching analysis based on the SEER database
    Hao Hu, Yang Xu, Qiang Zhang, Yuan Gao, Zhenyu Wu
    Expert Review of Anticancer Therapy.2024; 24(6): 467.     CrossRef
  • Neoadjuvant treatment of pancreatic ductal adenocarcinoma: Whom, when and how
    Nebojsa Manojlovic, Goran Savic, Stevan Manojlovic
    World Journal of Gastrointestinal Surgery.2024; 16(5): 1223.     CrossRef
  • Case Study on Analysing the Early Disease Detection of Pancreatic Ductal Adenocarcinoma in Korean Association for Clinical Oncology
    Sijithra Ponnarassery Chandran, N. Santhi
    American Journal of Clinical Oncology.2024; 47(10): 475.     CrossRef
  • Evaluating the benefits of adjuvant chemotherapy in patients with pancreatic cancer undergoing radical pancreatectomy after neoadjuvant therapy—a systematic review and meta-analysis
    Jiahao Wu, Yike Zhang, Haodong Wang, Wenyi Guo, Chengqing Li, Yichen Yu, Han Liu, Feng Li, Lei Wang, Jianwei Xu
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • 4,656 View
  • 156 Download
  • 4 Web of Science
  • 4 Crossref
Close layer
Pretreatment Lymph Node Metastasis as a Prognostic Significance in Cervical Cancer: Comparison between Disease Status
Soo Young Jeong, Hyea Park, Myeong Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Tae Joong Kim, Jeong Won Lee, Byoung-Gie Kim, Duk Soo Bae, Chel Hun Choi
Cancer Res Treat. 2020;52(2):516-523.   Published online October 29, 2019
DOI: https://doi.org/10.4143/crt.2019.328
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Lymph node metastasis (LNM) is the most significant prognostic factor in cervical cancer that was recently incorporated into the International Federation of Gynecology and Obstetrics (FIGO) staging system. This study was performed to evaluate whether the prognostic significance of LNM differs according to disease status.
Materials and Methods
Patients with FIGO stage IB or higher cervical cancer who had pretreatment computed tomography and/or magnetic resonance imaging studies as well as long-term follow-up were enrolled in this retrospective study. The hazard ratio (HR) of Cox regression was used to determine the prognostic significance of LNM. The HRs were compared between the different tumor groups (based on stage, histology, tumor size, primary treatment, age, parametrium involvement, and lymphovascular space invasion).
Results
A total of 970 patients treated between January 1999 and December 2007 were included. The pretreatment LNM had prognostic significance in patients with stage IB1/IIA (HR for progression-free survival 2.10, p=0.001; HR for overall survival 1.99, p=0.005). However, the significance gradually decreased or disappeared with advancing stages. Similarly, the prognostic significance of the pretreatment LNM decreased with advancing disease status, including old age, parametrial involvement or lymphovascular space involvement. In contrast, the tumor size was associated with the prognostic significance of LNM with advancing status. The significance of the clinical LNM did not reflect the significance of the clinical stage. In contrast, the tumor size, parametrial involvement, and significance of the pathologic LNM reflected the clinical stage.
Conclusion
In patients with cervical cancer, pretreatment LNM on imaging has different clinical significance depending on the tumor status.

Citations

Citations to this article as recorded by  
  • Development of cervical intraepithelial neoplasia and invasive cervical cancer due to oxidative stress
    Amir Asotić, Memić Asotić, Muhamed Memić, Kerim Asotić, Amra Asotić
    Sanamed.2024; 19(1): 39.     CrossRef
  • Investigating and Analyzing Prognostic Factors and Their Impact on Recurrent Cervical Cancers
    Ashish Uke, Shweta B Dahake, Anurag Luharia, Monika Luharia, Gaurav V Mishra, Chanrashekhar Mahakalkar
    Cureus.2024;[Epub]     CrossRef
  • Based on 3D-PDU and clinical characteristics nomogram for prediction of lymph node metastasis and lymph-vascular space invasion of early cervical cancer preoperatively
    Shuang Dong, Yan-Qing Peng, Ya-Nan Feng, Xiao-Ying Li, Li-Ping Gong, Shuang Zhang, Xiao-Shan Du, Li-Tao Sun
    BMC Women's Health.2024;[Epub]     CrossRef
  • Recent Advances in Cervical Cancer Management: A Review on Novel Prognostic Factors in Primary and Recurrent Tumors
    Angela Santoro, Frediano Inzani, Giuseppe Angelico, Damiano Arciuolo, Emma Bragantini, Antonio Travaglino, Michele Valente, Nicoletta D’Alessandris, Giulia Scaglione, Stefania Sfregola, Alessia Piermattei, Federica Cianfrini, Paola Roberti, Gian Franco Za
    Cancers.2023; 15(4): 1137.     CrossRef
  • Identification of lymph node metastasis in pre‐operation cervical cancer patients by weakly supervised deep learning from histopathological whole‐slide biopsy images
    Qingqing Liu, Nan Jiang, Yiping Hao, Chunyan Hao, Wei Wang, Tingting Bian, Xiaohong Wang, Hua Li, Yan zhang, Yanjun Kang, Fengxiang Xie, Yawen Li, XuJi Jiang, Yuan Feng, Zhonghao Mao, Qi Wang, Qun Gao, Wenjing Zhang, Baoxia Cui, Taotao Dong
    Cancer Medicine.2023; 12(17): 17952.     CrossRef
  • Roles of DWI and T2-weighted MRI volumetry in the evaluation of lymph node metastasis and lymphovascular invasion of stage IB–IIA cervical cancer
    Y. Wang, X. Chen, H. Pu, Y. Yuan, S. Li, G. Chen, Y. Liu, H. Li
    Clinical Radiology.2022; 77(3): 224.     CrossRef
  • Risk Factor Assessment of Lymph Node Metastasis in Patients With FIGO Stage IB1 Cervical Cancer
    Mu Xu, Xiaoyan Xie, Liangzhi Cai, Yongjin Xie, Qiao Gao, Pengming Sun
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Intravoxel Incoherent Motion (IVIM) MR Quantification in Locally Advanced Cervical Cancer (LACC): Preliminary Study on Assessment of Tumor Aggressiveness and Response to Neoadjuvant Chemotherapy
    Miriam Dolciami, Silvia Capuani, Veronica Celli, Alessandra Maiuro, Angelina Pernazza, Innocenza Palaia, Violante Di Donato, Giusi Santangelo, Stefania Maria Rita Rizzo, Paolo Ricci, Carlo Della Rocca, Carlo Catalano, Lucia Manganaro
    Journal of Personalized Medicine.2022; 12(4): 638.     CrossRef
  • The prognostic significance of pretreatment squamous cell carcinoma antigen levels in cervical cancer patients treated by concurrent chemoradiation therapy and a comparison of dosimetric outcomes and clinical toxicities between tomotherapy and volumetric
    Yuan-Kai Cheng, Shih-Hsun Kuo, Heng-Hsuan Yen, Jing-Hu Wu, Yu-Chieh Chen, Ming-Yii Huang
    Radiation Oncology.2022;[Epub]     CrossRef
  • What MRI-based tumor size measurement is best for predicting long-term survival in uterine cervical cancer?
    Njål Lura, Kari S. Wagner-Larsen, David Forsse, Jone Trovik, Mari K. Halle, Bjørn I. Bertelsen, Øyvind Salvesen, Kathrine Woie, Camilla Krakstad, Ingfrid S. Haldorsen
    Insights into Imaging.2022;[Epub]     CrossRef
  • Clinical value of MRI, serum SCCA, and CA125 levels in the diagnosis of lymph node metastasis and para-uterine infiltration in cervical cancer
    Chao Ran, Jian Sun, Yunhui Qu, Na Long
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • A Novel Four-Gene Prognostic Signature as a Risk Biomarker in Cervical Cancer
    Jun Wang, Hua Zheng, Yatian Han, Geng Wang, Yanbin Li, Cuida Meng
    International Journal of Genomics.2020; 2020: 1.     CrossRef
  • 9,773 View
  • 223 Download
  • 13 Web of Science
  • 12 Crossref
Close layer
Nomogram Development and External Validation for Predicting the Risk of Lymph Node Metastasis in T1 Colorectal Cancer
Jung Ryul Oh, Boram Park, Seongdae Lee, Kyung Su Han, Eui-Gon Youk, Doo-Han Lee, Do-Sun Kim, Doo-Seok Lee, Chang Won Hong, Byung Chang Kim, Bun Kim, Min Jung Kim, Sung Chan Park, Dae Kyung Sohn, Hee Jin Chang, Jae Hwan Oh
Cancer Res Treat. 2019;51(4):1275-1284.   Published online January 17, 2019
DOI: https://doi.org/10.4143/crt.2018.569
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Predicting lymph node metastasis (LNM) risk is crucial in determining further treatment strategies following endoscopic resection of T1 colorectal cancer (CRC). This study aimed to establish a new prediction model for the risk of LNM in T1 CRC patients.
Materials and Methods
The development set included 833 patients with T1 CRC who had undergone endoscopic (n=154) or surgical (n=679) resection at the National Cancer Center. The validation set included 722 T1 CRC patients who had undergone endoscopic (n=249) or surgical (n=473) resection at Daehang Hospital. A logistic regression model was used to construct the prediction model. To assess the performance of prediction model, discrimination was evaluated using the receiver operating characteristic (ROC) curves with area under the ROC curve (AUC), and calibration was assessed using the Hosmer-Lemeshow (HL) goodness-of-fit test.
Results
Five independent risk factors were determined in the multivariable model, including vascular invasion, high-grade histology, submucosal invasion, budding, and background adenoma. In final prediction model, the performance of the model was good that the AUC was 0.812 (95% confidence interval [CI], 0.770 to 0.855) and the HL chi-squared test statistic was 1.266 (p=0.737). In external validation, the performance was still good that the AUC was 0.771 (95% CI, 0.708 to 0.834) and the p-value of the HL chi-squared test was 0.040. We constructed the nomogram with the final prediction model.
Conclusion
We presented an externally validated new prediction model for LNM risk in T1 CRC patients, guiding decision making in determining whether additional surgery is required after endoscopic resection of T1 CRC.

Citations

Citations to this article as recorded by  
  • Risk stratification scores for lymph node metastases in T1 colorectal cancer—A systematic review
    Rakesh Quinn, Giuleta Jamsari, Ewan MacDermid
    Colorectal Disease.2025;[Epub]     CrossRef
  • The critical role of tumor size in predicting lymph node metastasis in early-stage colorectal cancer
    Attila Ulkucu, Metincan Erkaya, Ekin Inal, Emre Gorgun
    The American Journal of Surgery.2025; 241: 116152.     CrossRef
  • Risk assessment in pT1 colorectal cancer
    Emma Jane Norton, Adrian C Bateman
    Journal of Clinical Pathology.2024; 77(4): 225.     CrossRef
  • Curative criteria for endoscopic treatment of colorectal cancer
    Lucille Quénéhervé, Mathieu Pioche, Jérémie Jacques
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101883.     CrossRef
  • Commentary: An artificial intelligence prediction model outperforms conventional guidelines in predicting lymph node metastasis of T1 colorectal cancer
    Katsuro Ichimasa, Shin-ei Kudo, Khay Guan Yeoh
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Management after non-curative endoscopic resection of T1 rectal cancer
    Hao Dang, Daan A. Verhoeven, Jurjen J. Boonstra, Monique E. van Leerdam
    Best Practice & Research Clinical Gastroenterology.2024; 68: 101895.     CrossRef
  • A clinical-radiomics nomogram based on spectral CT multi-parameter images for preoperative prediction of lymph node metastasis in colorectal cancer
    Qian Li, Rui Hong, Ping Zhang, Liting Hou, Hailun Bao, Lin Bai, Jian Zhao
    Clinical & Experimental Metastasis.2024; 41(5): 639.     CrossRef
  • A new clinical model for predicting lymph node metastasis in T1 colorectal cancer
    Kai Wang, Hui He, Yanyun Lin, Yanhong Zhang, Junguo Chen, Jiancong Hu, Xiaosheng He
    International Journal of Colorectal Disease.2024;[Epub]     CrossRef
  • Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions
    Xu Song, Jun Li, Jiang Zhu, Yun-Fei Kong, Yu-Hang Zhou, Zi-Kun Wang, Jin Zhang
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Approaches and considerations in the endoscopic treatment of T1 colorectal cancer
    Yunho Jung
    The Korean Journal of Internal Medicine.2024; 39(4): 563.     CrossRef
  • A Nomogram for Predicting Unplanned Intraoperative Hypothermia in Patients With Colorectal Cancer Undergoing Laparoscopic Colorectal Procedures
    Lupei Yan, Jingxing Tan, Hao Chen, Han Xiao, Yi Zhang, Qin Yao, Yuerong Li
    AORN Journal.2023;[Epub]     CrossRef
  • A proposal for grading the risk of lymph node metastasis after endoscopic resection of T1 colorectal cancer
    Zhenghua Piao, Rong Ge, Chunnian Wang
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Nomogram as a novel predictive tool for lymph node metastasis in T1 colorectal cancer treated with endoscopic resection: a nationwide, multicenter study
    Yoshiki Kajiwara, Shiro Oka, Shinji Tanaka, Takahiro Nakamura, Shoichi Saito, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Kinichi Hotta, Hiroaki Ikematsu, Motohiro Kojima, Yutaka Saito, Masayoshi Yamada, Yukihide Kanemitsu, Shigeki Sekine, Shinji
    Gastrointestinal Endoscopy.2023; 97(6): 1119.     CrossRef
  • CT morphological features for predicting the risk of lymph node metastasis in T1 colorectal cancer
    Suyun Li, Zhenhui Li, Li Wang, Mimi Wu, Xiaobo Chen, Chutong He, Yao Xu, Mengyi Dong, Yanting Liang, Xin Chen, Zaiyi Liu
    European Radiology.2023; 33(10): 6861.     CrossRef
  • Prediction model for lymph node metastasis in superficial colorectal cancer: a better choice than computed tomography
    Chao-Tao Tang, Jun Li, Peng Wang, You-Xiang Chen, Chun-Yan Zeng
    Surgical Endoscopy.2023; 37(10): 7444.     CrossRef
  • Lymph Node Molecular Analysis with OSNA Enables the Identification of pT1 CRC Patients at Risk of Recurrence: A Multicentre Study
    Karmele Saez de Gordoa, Maria Teresa Rodrigo-Calvo, Ivan Archilla, Sandra Lopez-Prades, Alba Diaz, Jordi Tarragona, Isidro Machado, Juan Ruiz Martín, Diana Zaffalon, Maria Daca-Alvarez, Maria Pellisé, Jordi Camps, Miriam Cuatrecasas
    Cancers.2023; 15(22): 5481.     CrossRef
  • Prediction of disease recurrence or residual disease after primary endoscopic resection of pT1 colorectal cancer—results from a large nationwide Danish study
    Ilze Ose, Katarina Levic, Lau Caspar Thygesen, Orhan Bulut, Thue Bisgaard, Ismail Gögenur, Tine Plato Kuhlmann
    International Journal of Colorectal Disease.2023;[Epub]     CrossRef
  • Endoscopic resection alone as a potential treatment method for low-risk deep invasive T1 colorectal cancer
    Yuta Kouyama, Shin-ei Kudo, Katsuro Ichimasa, Shingo Matsudaira, Yushi Ogawa, Kenichi Mochizuki, Yuki Takashina, Yuta Sato, Tatsuya Sakurai, Yasuharu Maeda, Hiroki Nakamura, Masashi Misawa, Yuichi Mori, Toyoki Kudo, Takemasa Hayashi, Kunihiko Wakamura, Te
    iGIE.2023; 2(4): 503.     CrossRef
  • A Retrospective Multicenter Study of Risk Factors, Stratification, and Prognosis of Lymph Node Metastasis in T1 and T2 Colorectal Cancer
    Eui Myung Kim, Il Tae Son, Byung Chun Kim, Jun Ho Park, Byung Mo Kang, Jong Wan Kim
    Journal of Clinical Medicine.2023; 12(24): 7744.     CrossRef
  • Risk and Time Pattern of Recurrences After Local Endoscopic Resection of T1 Colorectal Cancer: A Meta-analysis
    Hao Dang, Nik Dekkers, Saskia le Cessie, Jeanin E. van Hooft, Monique E. van Leerdam, Philip P. Oldenburg, Louis Flothuis, Jan W. Schoones, Alexandra M.J. Langers, James C.H. Hardwick, Jolein van der Kraan, Jurjen J. Boonstra
    Clinical Gastroenterology and Hepatology.2022; 20(2): e298.     CrossRef
  • Lymphatic Node Metastasis Risk Scoring System: A Novel Instrument for Predicting Lymph Node Metastasis After Thymic Epithelial Tumor Resection
    Xinxin Cheng, Yaxin Lu, Sai Chen, Weilin Yang, Bo Xu, Jianyong Zou, Zhenguang Chen
    Annals of Surgical Oncology.2022; 29(1): 598.     CrossRef
  • Current problems and perspectives of pathological risk factors for lymph node metastasis in T1 colorectal cancer: Systematic review
    Katsuro Ichimasa, Shin‐ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Yasuharu Maeda, Yuichi Mori, Toyoki Kudo, Yuki Miyata, Yoshika Akimoto, Yuki Kataoka, Takafumi Kubota, Tetsuo Nemoto, Fumio Ishida, Masashi Misawa
    Digestive Endoscopy.2022; 34(5): 901.     CrossRef
  • Tumor Location as a Prognostic Factor in T1 Colorectal Cancer
    Katsuro Ichimasa, Shin-ei Kudo, Yuta Kouyama, Kenichi Mochizuki, Yuki Takashina, Masashi Misawa, Yuichi Mori, Takemasa Hayashi, Kunihiko Wakamura, Hideyuki Miyachi
    Journal of the Anus, Rectum and Colon.2022; 6(1): 9.     CrossRef
  • Identification of Predictive Factors for Lymph Node Metastasis in pT1 Stage Colorectal Cancer Patients: A Retrospective Analysis Based on the Population Database
    Jiawei Song, Huanhuan Yin, Yong Zhu, Shengqi Fei
    Pathology and Oncology Research.2022;[Epub]     CrossRef
  • Establishment of a Dynamic Nomogram for Predicting the Risk of Lymph Node Metastasis in T1 Stage Colorectal Cancer
    Zitao Liu, Chao Huang, Huakai Tian, Yu Liu, Yongshan Huang, Zhengming Zhu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Deep Submucosal Invasion Is Not an Independent Risk Factor for Lymph Node Metastasis in T1 Colorectal Cancer: A Meta-Analysis
    Liselotte W. Zwager, Barbara A.J. Bastiaansen, Nahid S.M. Montazeri, Roel Hompes, Valeria Barresi, Katsuro Ichimasa, Hiroshi Kawachi, Isidro Machado, Tadahiko Masaki, Weiqi Sheng, Shinji Tanaka, Kazutomo Togashi, Chihiro Yasue, Paul Fockens, Leon M.G. Moo
    Gastroenterology.2022; 163(1): 174.     CrossRef
  • Composite scoring system and optimal tumor budding cut-off number for estimating lymph node metastasis in submucosal colorectal cancer
    Jeong-ki Kim, Ye-Young Rhee, Jeong Mo Bae, Jung Ho Kim, Seong-Joon Koh, Hyun Jung Lee, Jong Pil Im, Min Jung Kim, Seung-Bum Ryoo, Seung-Yong Jeong, Kyu Joo Park, Ji Won Park, Gyeong Hoon Kang
    BMC Cancer.2022;[Epub]     CrossRef
  • Lymph node metastasis in T1 colorectal cancer with the only high-risk histology of submucosal invasion depth ≥ 1000 μm
    Yusuke Yamaoka, Akio Shiomi, Hiroyasu Kagawa, Hitoshi Hino, Shoichi Manabe, Kai Chen, Kenji Nanishi, Akifumi Notsu
    International Journal of Colorectal Disease.2022; 37(11): 2387.     CrossRef
  • Subpopulation analysis of survival in high-risk T1 colorectal cancer: surgery versus endoscopic resection only
    Ryun Kyong Ha, Boram Park, Kyung Su Han, Dae Kyung Sohn, Chang Won Hong, Byung Chang Kim, Bun Kim, Sung Chan Park, Hee Jin Chang, Jae Hwan Oh
    Gastrointestinal Endoscopy.2022; 96(6): 1036.     CrossRef
  • Preoperative prediction of lymph node status in patients with colorectal cancer. Developing a predictive model using machine learning
    Morten Hartwig, Karoline Bendix Bräuner, Rasmus Vogelsang, Ismail Gögenur
    International Journal of Colorectal Disease.2022; 37(12): 2517.     CrossRef
  • Preoperative Predictors of Lymph Node Metastasis in Colon Cancer
    Yansong Xu, Yi Chen, Chenyan Long, Huage Zhong, Fangfang Liang, Ling-xu Huang, Chuanyi Wei, Shaolong Lu, Weizhong Tang
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • LASSO-Based Machine Learning Algorithm for Prediction of Lymph Node Metastasis in T1 Colorectal Cancer
    Jeonghyun Kang, Yoon Jung Choi, Im-kyung Kim, Hye Sun Lee, Hogeun Kim, Seung Hyuk Baik, Nam Kyu Kim, Kang Young Lee
    Cancer Research and Treatment.2021; 53(3): 773.     CrossRef
  • Risk Stratification of T1 Colorectal Cancer Metastasis to Lymph Nodes: Current Status and Perspective
    Katsuro Ichimasa, Shin-ei Kudo, Hideyuki Miyachi, Yuta Kouyama, Masashi Misawa, Yuichi Mori
    Gut and Liver.2021; 15(6): 818.     CrossRef
  • Supervised Learning Based Systemic Inflammatory Markers Enable Accurate Additional Surgery for pT1NxM0 Colorectal Cancer: A Comparative Analysis of Two Practical Prediction Models for Lymph Node Metastasis
    Jinlian Jin, Haiyan Zhou, Shulin Sun, Zhe Tian, Haibing Ren, Jinwu Feng
    Cancer Management and Research.2021; Volume 13: 8967.     CrossRef
  • Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer
    Kaibo Guo, Yuqian Feng, Li Yuan, Harpreet S. Wasan, Leitao Sun, Minhe Shen, Shanming Ruan
    Cancer Medicine.2020; 9(14): 5095.     CrossRef
  • Development and external validation of a predictive scoring system associated with metastasis of T1‐2 colorectal tumors to lymph nodes
    Shaobo Mo, Zheng Zhou, Weixing Dai, Wenqiang Xiang, Lingyu Han, Long Zhang, Renjie Wang, Sanjun Cai, Qingguo Li, Guoxiang Cai
    Clinical and Translational Medicine.2020; 10(1): 275.     CrossRef
  • Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population-Based Study
    Qing-Wei Zhang, Long-Ci Sun, Chao-Tao Tang, Qian Liang, Yang-Yang Zhou, Hui-Min Chen, Yun-Jie Gao, Zhi-Zheng Ge
    The Oncologist.2020; 25(6): e920.     CrossRef
  • T1 colorectal cancers: The impact of screening programs on a curable disease
    Adriana Vaz Safatle-Ribeiro
    Digestive and Liver Disease.2020; 52(8): 918.     CrossRef
  • Risk factors and risk prediction models for colorectal cancer metastasis and recurrence: an umbrella review of systematic reviews and meta-analyses of observational studies
    Wei Xu, Yazhou He, Yuming Wang, Xue Li, Jane Young, John P. A. Ioannidis, Malcolm G. Dunlop, Evropi Theodoratou
    BMC Medicine.2020;[Epub]     CrossRef
  • 10,090 View
  • 377 Download
  • 39 Web of Science
  • 39 Crossref
Close layer
Prognostic Value and Staging Classification of Lymph Nodal Necrosis in Nasopharyngeal Carcinoma after Intensity-Modulated Radiotherapy
Yanru Feng, Caineng Cao, Qiaoying Hu, Xiaozhong Chen
Cancer Res Treat. 2019;51(3):1222-1230.   Published online December 27, 2018
DOI: https://doi.org/10.4143/crt.2018.595
AbstractAbstract PDFPubReaderePub
Purpose
The aim of the present study was to evaluate the prognostic value of magnetic resonance imaging (MRI)‒determined lymph nodal necrosis (LNN) in nasopharyngeal carcinoma (NPC) and explore the feasibility of an N-classification system based on the 8th edition of the American Joint Committee on Cancer (AJCC) system.
Materials and Methods
The MRI scans of 616 patients with newly diagnosed stage T1-4N1-3M0 NPC who were treated with definitive intensity-modulated radiotherapy (IMRT) were reviewed.
Results
Multivariate analysis showed that LNN was an independent negative prognostic predictor of distant metastasis free survival (hazard ratio, 1.634; 95% confidence interval, 1.023 to 2.609; p=0.040) and overall survival (hazard ratio, 2.154; 95% confidence interval, 1.282 to 3.620; p=0.004). Patients of classification N1 disease with LNN were reclassified as classification N2, and classification N2 disease with LNN as classification N3 in the proposed N-classification system. Correlation with death and distant failure was significant, and the total difference between N1 and N3 was wider with the proposed system.
Conclusion
MRI-determined LNN is an independent negative prognostic factor for NPC. The proposed N classification system is powerfully predictive.

Citations

Citations to this article as recorded by  
  • Matted Lymph Nodes on MRI in Nasopharyngeal Carcinoma: Prognostic Factor and Potential Indication for Induction Chemotherapy Benefits
    Annan Dong, Siyu Zhu, Huali Ma, Xiaoyu Wei, Wenjie Huang, Guangying Ruan, Lizhi Liu, Yunxian Mo, Fei Ai
    Journal of Magnetic Resonance Imaging.2024; 59(6): 1976.     CrossRef
  • Statistical and machine learning methods for cancer research and clinical practice: A systematic review
    Laura Lopez-Perez, Eleni Georga, Carlo Conti, Victor Vicente, Rebeca García, Leandro Pecchia, Dimitris Fotiadis, Lisa Licitra, Maria Fernanda Cabrera, Maria Teresa Arredondo, Giuseppe Fico
    Biomedical Signal Processing and Control.2024; 92: 106067.     CrossRef
  • The Prognostic Value of Serum Sialic Acid in Patients with Nasopharyngeal Carcinoma: A Propensity Score Matching Study
    Zetan Chen, Gang Wu, Xiangying Lin, Xiaopeng Huang, Shuai Zhang, Kaihua Chen, Zhongguo Liang, Xiaodong Zhu
    Cancer Management and Research.2024; Volume 16: 215.     CrossRef
  • A prognostic nomogram incorporating tumor size and lymph node size for patients with nasopharyngeal carcinoma
    Qi Yi, Jiazuo Cai, Yunen Lin, Zimei Hu, Jie Lin, Zhong Huang, Wei Liu, Ronghui Zheng, YaWei Yuan, Chengcong Chen
    American Journal of Otolaryngology.2023; 44(2): 103717.     CrossRef
  • Intra- and peritumoral MRI radiomics assisted in predicting radiochemotherapy response in metastatic cervical lymph nodes of nasopharyngeal cancer
    Hao Xu, Ai Wang, Chi Zhang, Jing Ren, Peng Zhou, Jieke Liu
    BMC Medical Imaging.2023;[Epub]     CrossRef
  • Construction of Prognostic Nomogram in Patients with N3-Stage Nasopharyngeal Carcinoma
    Wenmiao Cao, Xiaoxin Li, Jianqi Yang, Enming Xing, Wenjuan Wu, Yizhi Ge, Buhai Wang
    ORL.2023; 85(4): 195.     CrossRef
  • Detection and staging of recurrent or metastatic nasopharyngeal carcinoma in the era of FDG PET/MR
    Yongfeng Piao, Caineng Cao, Yuanfan Xu, Shuang Huang, Feng Jiang, Ting Jin, Qifeng Jin, Yonghong Hua, Qiaoying Hu, Xiaozhong Chen
    European Archives of Oto-Rhino-Laryngology.2022; 279(1): 353.     CrossRef
  • A nonendemic analysis of the patterns and prognosis of de novo metastatic nasopharyngeal carcinomas in older patients aged ≥ 65 years
    Baoqiu Liu, Mingxing Zhang, Yanqing Cao, Zhe Wang, Xicheng Wang
    Scientific Reports.2022;[Epub]     CrossRef
  • Prognostic value of cervical nodal necrosis on staging imaging of nasopharyngeal carcinoma in era of intensity-modulated radiotherapy: a systematic review and meta-analysis
    Qi-Yong H. Ai, Kuo Feng Hung, Tiffany Y. So, Frankie K. F. Mo, Wing Tsung Anthony Chin, Edwin P. Hui, Brigette B. Y. Ma, Michael Ying, Ann D. King
    Cancer Imaging.2022;[Epub]     CrossRef
  • Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study
    Yuanxiu Yin, Ziyan Zhou, Zhiru Li, Mingjun Shen, Yating Qin, Chaolin Yang, Rensheng Wang, Min Kang
    Radiation Oncology.2022;[Epub]     CrossRef
  • FMISO-Based Adaptive Radiotherapy in Head and Neck Cancer
    Martin Dolezel, Marek Slavik, Tomas Blazek, Tomas Kazda, Pavel Koranda, Lucia Veverkova, Petr Burkon, Jakub Cvek
    Journal of Personalized Medicine.2022; 12(8): 1245.     CrossRef
  • Prognostic value of the cervical lymph node necrosis ratio in nasopharyngeal carcinoma
    Ying Bin, Zhen Meng, Lu-Lu Huang, Xue-Ying Hu, Jun-Mei Song, Yi-Ting Xie, Min Kang, Ren-Sheng Wang
    Radiotherapy and Oncology.2022; 177: 185.     CrossRef
  • Influence of tumor necrosis on treatment sensitivity and long-term survival in nasopharyngeal carcinoma
    Shao-Bo Liang, Lu-Si Chen, Xing-Li Yang, Dan-Ming Chen, Dong-Hui Wang, Chun-Yan Cui, Chuan-Bo Xie, Li-Zhi Liu, Xiang-Ying Xu
    Radiotherapy and Oncology.2021; 155: 219.     CrossRef
  • Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis
    Wanpeng Li, Hanyu Lu, Huan Wang, Li Hu, Xicai Sun, Hongmeng Yu, Dehui Wang
    Head & Neck.2021; 43(8): 2353.     CrossRef
  • Contemporary management of the neck in nasopharyngeal carcinoma
    Wai Tong Ng, Raymond K. Y. Tsang, Jonathan J. Beitler, Remco de Bree, Andrés Coca‐Pelaz, Avraham Eisbruch, Orlando Guntinas‐Lichius, Anne W. M. Lee, Antti A. Mäkitie, William M. Mendenhall, Sandra Nuyts, Alessandra Rinaldo, K. Thomas Robbins, Juan P. Rodr
    Head & Neck.2021; 43(6): 1949.     CrossRef
  • MRI-based radiomics as response predictor to radiochemotherapy for metastatic cervical lymph node in nasopharyngeal carcinoma
    Hao Xu, Jieke Liu, Ying Huang, Peng Zhou, Jing Ren
    The British Journal of Radiology.2021;[Epub]     CrossRef
  • Long-term survival outcomes and adverse effects of nasopharyngeal carcinoma patients treated with IMRT in a non-endemic region: a population-based retrospective study
    Man Xu, Jian Zang, Shanquan Luo, Jianhua Wang, Xuqi Li
    BMJ Open.2021; 11(8): e045417.     CrossRef
  • Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature
    Chi Leung Chiang, Qiaojuan Guo, Wai Tong Ng, Shaojun Lin, Tiffany Sze Wai Ma, Zhiyuan Xu, Youping Xiao, Jishi Li, Tianzhu Lu, Horace Cheuk Wai Choi, Wenqi Chen, Eric Sze Chun Chau, Peter Ho Yin Luk, Shao Hui Huang, Brian O’Sullivan, Jianji Pan, Anne Wing
    Frontiers in Oncology.2021;[Epub]     CrossRef
  • Long-term outcomes of induction chemotherapy followed by intensity-modulated radiotherapy and adjuvant chemotherapy in nasopharyngeal carcinoma patients with N3 disease
    Xiaoshuang Niu, Fen Xue, Peiyao Liu, Chaosu Hu, Xiayun He
    Translational Oncology.2021; 14(12): 101216.     CrossRef
  • Prognostic value and the potential role of treatment options for cervical lymph node necrosis in nasopharyngeal carcinoma
    Kuiyuan Liu, Siting Lin, Liangru Ke, Weixiong Xia, Chun Zhang, Jianpeng Li, Mingyong Gao, Mengyun Qiang, Xi Chen, Jia Liu, Chuanmiao Xie, Xiang Guo, Xing Lv
    Oral Oncology.2020; 109: 104864.     CrossRef
  • The evolution of the nasopharyngeal carcinoma staging system over a 10-year period: implications for future revisions
    Si-Qi Tang, Yan-Ping Mao, Cheng Xu, Rui Guo, Wen-Fei Li, Ling-Long Tang, Ying Sun, Jun Ma
    Chinese Medical Journal.2020; 133(17): 2044.     CrossRef
  • Prognostic and Treatment Guiding Significance of MRI-Based Tumor Burden Features and Nodal Necrosis in Nasopharyngeal Carcinoma
    Xi Chen, Xun Cao, Bingzhong Jing, Weixiong Xia, Liangru Ke, Yanqun Xiang, Kuiyuan Liu, Mengyun Qiang, Chixiong Liang, Jianpeng Li, Mingyong Gao, Wangzhong Li, Jingjing Miao, Guoying Liu, Zhuochen Cai, Shuhui Lv, Xiang Guo, Chaofeng Li, Xing Lv
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • Patterns and Prognostic Value of Lymph Node Metastasis on Distant Metastasis and Survival in Nasopharyngeal Carcinoma: A Surveillance, Epidemiology, and End Results Study, 2006–2015
    Yali Xu, Taoyuan Huang, Liqin Fan, Wei Jin, Xiaoming Chen, Jinhai Chen
    Journal of Oncology.2019; 2019: 1.     CrossRef
  • Screening of key miRNAs and evaluation of their diagnostic and prognostic values in nasopharyngeal carcinoma
    Xianlu Zhuo, Wei Zhou, Huiping Ye, Dairong Li, Aoshuang Chang, Yongzhong Wu, Qi Zhou
    Oncology Letters.2019;[Epub]     CrossRef
  • 7,985 View
  • 170 Download
  • 26 Web of Science
  • 24 Crossref
Close layer
Axillary Lymph Node Dissection Does Not Improve Post-mastectomy Overall or Disease-Free Survival among Breast Cancer Patients with 1-3 Positive Nodes
Ji Hyeon Joo, Su Ssan Kim, Byung Ho Son, Seung Do Ahn, Jin Hong Jung, Eun Kyung Choi, Sei Hyun Ahn, Jong Won Lee, Hee Jeong Kim, Beom Seok Ko
Cancer Res Treat. 2019;51(3):1011-1021.   Published online October 16, 2018
DOI: https://doi.org/10.4143/crt.2018.438
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
Axillary lymph node dissection (ALND) may be avoidable for breast cancer patients with 1-2 positive lymph nodes (LN) after breast-conserving therapy. However, the effects of ALND after mastectomy remain unclear because radiation is not routinely used. Herein, we compared the benefits of post-mastectomy ALND versus sentinel node biopsy (SNB) alone for breast cancer patients with 1-3 metastatic LNs.
Materials and Methods
A total of 1,697 patients with pN1 disease who underwent mastectomy during 2000-2015 were identified from an institutional database. Outcomes were compared using the inverse probability of treatment weighted method.
Results
Patients who underwent SNB tended to have smaller tumors, a lower histology grade, a lower number of positive LNs, and better immunohistochemical findings. After correcting all confounding factors regarding patient, tumor, and adjuvant treatment, the SNB and ALND groups did not differ in terms of overall survival (OS) and disease-free survival (DFS), distant metastasis and locoregional recurrence. The 10-year DFS and OS rates were 83% and 84%, respectively, during a median follow-up period of 93 months.
Conclusion
ALND did not improve post-mastectomy survival outcomes among patients with N1 breast cancer, even after adjusting for all histopathologic and treatment-related factors.

Citations

Citations to this article as recorded by  
  • The Impact of Sentinel Lymph Node Biopsy on Female Patients With T3-4c Breast Cancer and 1-2 Positive Lymph Nodes: A Population-Based Cohort Study
    Hanzhao Yang, Yadong Sun, Peili Wang, Jianghua Qiao, Chengzheng Wang, Zhenzhen Liu
    Clinical Breast Cancer.2024; 24(3): e126.     CrossRef
  • Axillary management in patients with clinical node-negative early breast cancer and positive sentinel lymph node: a systematic review and meta-analysis
    Changzai Li, Pan Zhang, Jie Lv, Wei Dong, Baoshan Hu, Jinji Zhang, Hongcheng Zhu
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Reevaluating Axillary Lymph Node Dissection in Total Mastectomy for Low Axillary Burden Breast Cancer: Insights from a Meta-Analysis including the SINODAR-ONE Trial
    Munaser Alamoodi, Neill Patani, Kinan Mokbel, Umar Wazir, Kefah Mokbel
    Cancers.2024; 16(4): 742.     CrossRef
  • RecurIndex-Guided postoperative radiotherapy with or without Avoidance of Irradiation of regional Nodes in 1–3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial
    Jing Liu, Yuting Tan, Zhuofei Bi, Suning Huang, Na Zhang, An-du Zhang, Lina Zhao, Yu Wang, Zibin Liang, Yu Hou, Xiangying Xu, Jianying Chen, Fei Wang, Xiaowen Lan, Xiao Lin, Xiaoxue Zhang, Wenyi Zhou, Xuting Ye, Jian-gui Guo, Xiaohong Wang, Ran Ding, Jiay
    BMJ Open.2024; 14(7): e078049.     CrossRef
  • The prognostic analysis of further axillary dissection in breast cancer with 1-2 positive sentinel lymph nodes undergoing mastectomy
    Xueyi Zhao, Liu Yang, Congbo Cao, Zhenchuan Song
    Frontiers in Oncology.2024;[Epub]     CrossRef
  • Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy
    Damiano GENTILE, Corrado TINTERRI
    Minerva Surgery.2024;[Epub]     CrossRef
  • Can Axillary Lymph Node Dissection be Omitted in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes Undergoing Mastectomy? A Systematic Review and Meta‐Analysis of Real‐World Evidence
    Fulong Chen, Xiaowen Li, Xianjun Lin, Lijia Chen, Zhaoling Lin, Hao Wu, Jishang Chen
    World Journal of Surgery.2023; 47(10): 2446.     CrossRef
  • De-implementation of Axillary Dissection in Women Undergoing Mastectomy for Breast Cancer
    Laura D. Leonard, Thiago B. de Araujo, Christopher Quinn, Madeline B. Thomas, Laurel Beaty, Nicole M. Mott, Kathryn Colborn, Alicia A. Heelan, Sarah E. A. Tevis, Nicole Christian, Gretchen Arhendt, Ana L. Gleisner
    Annals of Surgical Oncology.2023; 30(9): 5692.     CrossRef
  • A multi-dimensional nomogram to predict non-sentinel lymph node metastases in T1–2HR+ breast cancer
    Ke Xiang, Jialin Chen, Yu Min, Hang Chen, Jiaxin Yang, Daixing Hu, Yuling Han, Guobing Yin, Yang Feng
    Frontiers in Endocrinology.2023;[Epub]     CrossRef
  • Sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer patients undergoing mastectomy with one to two metastatic sentinel lymph nodes: sub-analysis of the SINODAR-ONE multicentre randomized clinical trial and reopening of enrolm
    Corrado Tinterri, Giuseppe Canavese, Wolfgang Gatzemeier, Erika Barbieri, Alberto Bottini, Andrea Sagona, Giulia Caraceni, Alberto Testori, Simone Di Maria Grimaldi, Carla Dani, Luca Boni, Paolo Bruzzi, Bethania Fernandes, Marta Scorsetti, Alberto Zambell
    British Journal of Surgery.2023; 110(9): 1143.     CrossRef
  • Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis
    Yu-Jia Fan, Jin-Cheng Li, De-Miao Zhu, Hai-Long Zhu, Yi Zhao, Xin-Bing Zhu, Gang Wu, Ting-ting Bai
    BMC Surgery.2023;[Epub]     CrossRef
  • Factores predictivos de metástasis en ganglios no centinela en el cáncer de mama con ganglio centinela positivo
    Mariana Peyroteo, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Cátia Ribeiro, Paulo Reis, Abreu de Sousa
    Cirugía Española.2022; 100(2): 81.     CrossRef
  • Optimizing Axillary Management in Clinical T1-2N0 Mastectomy Patients with Positive Sentinel Lymph Nodes
    Olga Kantor, Jessica Means, Samantha Grossmith, Tanujit Dey, Jennifer R. Bellon, Elizabeth A. Mittendorf, Tari A. King
    Annals of Surgical Oncology.2022; 29(2): 972.     CrossRef
  • Predictive factors of non-sentinel lymph node disease in breast cancer patients with positive sentinel lymph node
    Mariana Peyroteo, Rita Canotilho, Ana Margarida Correia, Catarina Baía, Cátia Ribeiro, Paulo Reis, Abreu de Sousa
    Cirugía Española (English Edition).2022; 100(2): 81.     CrossRef
  • Axilla lymph node dissection can be safely omitted in patients with 1–2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis
    Weiqi Gao, Shuangshuang Lu, Yufei Zeng, Xiaosong Chen, Kunwei Shen
    Breast Cancer Research and Treatment.2022; 196(1): 129.     CrossRef
  • Comparison of survival outcomes between axillary conservation and axillary lymph node dissections in N1 early breast cancer: a propensity-matched SEER analysis
    Nisha Wu, Xiaohan Su, Qiao Tan, Jing Luo, Yewei Yuan, Lingmi Hou, Junyan Li
    Clinical and Translational Oncology.2022; 25(4): 1091.     CrossRef
  • Surgeon Bias in the Management of Positive Sentinel Lymph Nodes
    Brittany J. Mathias, James Sun, Weihong Sun, Jun-Min Zhou, William J. Fulp, Christine Laronga, M. Catherine Lee, John V. Kiluk
    Clinical Breast Cancer.2021; 21(1): 74.     CrossRef
  • Impact of Axillary Dissection Among Patients With Sentinel Node–Positive Breast Cancer Undergoing Mastectomy
    James Sun, Brittany J. Mathias, Christine Laronga, Weihong Sun, Jun-Min Zhou, William J. Fulp, John V. Kiluk, M. Catherine Lee
    Journal of the National Comprehensive Cancer Network.2021; 19(1): 40.     CrossRef
  • Evolution of the Use of Completion Axillary Lymph Node Dissection in Patients with T1/2N0M0 Breast Cancer and Tumour-Involved Sentinel Lymph Nodes Undergoing Mastectomy: A Cohort Study
    André Hennigs, Fabian Riedel, Manuel Feißt, Melitta Köpke, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Jörg Heil
    Annals of Surgical Oncology.2019; 26(8): 2435.     CrossRef
  • 8,965 View
  • 326 Download
  • 18 Web of Science
  • 19 Crossref
Close layer
Which Patients with Isolated Para-aortic Lymph Node Metastasis Will Truly Benefit from Extended Lymph Node Dissection for Colon Cancer?
Sung Uk Bae, Hyuk Hur, Byung Soh Min, Seung Hyuk Baik, Kang Young Lee, Nam Kyu Kim
Cancer Res Treat. 2018;50(3):712-719.   Published online July 14, 2017
DOI: https://doi.org/10.4143/crt.2017.100
AbstractAbstract PDFPubReaderePub
Purpose
The prognosis of patientswith colon cancer and para-aortic lymph node metastasis (PALNM) is poor. We analyzed the prognostic factors of extramesenteric lymphadenectomy for colon cancer patients with isolated PALNM.
Materials and Methods
We retrospectively reviewed 49 patients with PALNM who underwent curative resection between October 1988 and December 2009.
Results
In univariate analyses, the 5-year overall survival (OS) and disease-free survival (DFS) rates were higher in patients with ≤ 7 positive para-aortic lymph node (PALN) (36.5% and 27.5%) than in those with > 7 PALN (14.3% and 14.3%; p=0.010 and p=0.027, respectively), and preoperative carcinoembryonic antigen (CEA) level > 5 was also correlated with a lower 5-year OS and DFS rate of 21.5% and 11.7% compared with those with CEA ≤ 5 (46.3% and 41.4%; p=0.122 and 0.039, respectively). Multivariate analysis found that the number of positive PALN (hazard ratio [HR], 3.291; 95% confidence interval [CI], 1.309 to 8.275; p=0.011) was an independent prognostic factor for OS and the number of positive PALN (HR, 2.484; 95% CI, 0.993 to 6.211; p=0.052) and preoperative CEA level (HR, 1.953; 95% CI, 0.940 to 4.057; p=0.073) were marginally independent prognostic factors for DFS. According to our prognostic model, the 5-year OS and DFS rate increased to 59.3% and 53.3%, respectively, in patients with ≤ 7 positive PALN and CEA level ≤ 5.
Conclusion
PALN dissection might be beneficial in carefully selected patients with a low CEA level and less extensive PALNM.

Citations

Citations to this article as recorded by  
  • Prognostic factors of para-aortic lymph node metastasis from colorectal cancer in highly selected patients undergoing para-aortic lymph node dissection
    Shin Emoto, Yosuke Fukunaga, Manabu Takamatsu, Hiroshi Kawachi, Shuhei Sano, Tetsuro Tominaga, Toshiki Mukai, Tomohiro Yamaguchi, Toshiya Nagasaki, Takashi Akiyoshi, Tsuyoshi Konishi, Satoshi Nagayama, Masashi Ueno
    Surgery Today.2024; 54(4): 356.     CrossRef
  • Metastatic Colorectal Cancer Treated with Combined Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Predictive Factors for Early Recurrence
    Rémi Grange, Pascal Rousset, Nicolas Williet, Mathias Guesnon, Laurent Milot, Guillaume Passot, Jean-Marc Phelip, Bertrand Le Roy, Olivier Glehen, Vahan Kepenekian
    Annals of Surgical Oncology.2024; 31(4): 2378.     CrossRef
  • Para-aortic Lymph Node Dissection for Colorectal Cancer: Predicting Pathologic Lymph Node Positivity and Optimizing Outcomes
    Neal Bhutiani, Kentaro Ochiai, Muhammad O. Awiwi, Miguel A. Rodriguez-Bigas, Abhineet Uppal, Oliver Peacock, Craig Messick, Michael G. White, John M. Skibber, Brian K. Bednarski, Y. Nancy You, George J. Chang, Harmeet Kaur, Tsuyoshi Konishi
    Annals of Surgical Oncology.2024; 31(9): 5962.     CrossRef
  • Surgery for Infrarenal Retroperitoneal Node Metastases from Colon Cancer
    Anne-Sophie Dulac, Pietro Genova, Olivier Benoit, Cindy Neuzillet, Mostapha El Hajjam, Jean-François Emile, Frédérique Peschaud, Renato Micelli Lupinacci
    Journal of Gastrointestinal Cancer.2024; 55(3): 1306.     CrossRef
  • Long-term Outcome After Surgical Resection of Para-aortic Lymph Node Metastasis of Colorectal Cancer: A Multicenter Retrospective Study
    Sono Ito, Yusuke Kinugasa, Shinichi Yamauchi, Hiroyuki Sato, Akihiro Hirakawa, Soichiro Ishihara, Akio Shiomi, Yukihide Kanemitsu, Takeshi Suto, Hiroki Takahashi, Michio Itabashi, Manabu Shiozawa, Masaya Hiyoshi, Takaya Kobatake, Koji Komori, Hiroyuki Egi
    Diseases of the Colon & Rectum.2024; 67(11): 1423.     CrossRef
  • Long-Term Outcome After Resection of Hepatic and Pulmonary Metastases in Multivisceral Colorectal Cancer
    Christopher Berlin, Geoffroy Andrieux, Magdalena Menzel, Gabriel J. Stöger, Andreas Gengenbach, Luisa Schäfer, Hans C. Hillebrecht, Rebecca Kesselring, Uyen-Thao Le, Stefan Fichtner-Feigl, Philipp A. Holzner
    Cancers.2024; 16(22): 3741.     CrossRef
  • Role of Adjuvant Chemotherapy After Surgical Resection of Paraaortic Lymph Node Metastasis from Colorectal Cancer—A Multicenter Retrospective Study
    Hiroaki Nozawa, Sono Ito, Kazuhito Sasaki, Koji Murono, Shigenobu Emoto, Yuichiro Yokoyama, Shinichi Yamauchi, Yusuke Kinugasa, Yoichi Ajioka, Soichiro Ishihara
    Annals of Surgical Oncology.2024;[Epub]     CrossRef
  • Survival outcomes after synchronous para‐aortic lymph node metastasis in colorectal cancer: A systematic review
    Conor Aylward, Jawed Noori, Jack Tyrrell, Niall O'sullivan, Dara O. Kavanagh, John O. Larkin, Brian J. Mehigan, Paul H. McCormick, Michael E. Kelly
    Journal of Surgical Oncology.2023; 127(4): 645.     CrossRef
  • Retroperitoneal Lymph Node Dissection in Colorectal Cancer with Lymph Node Metastasis: A Systematic Review
    Michael G. Fadel, Mosab Ahmed, Gianluca Pellino, Shahnawaz Rasheed, Paris Tekkis, David Nicol, Christos Kontovounisios, Erik Mayer
    Cancers.2023; 15(2): 455.     CrossRef
  • The management of clinically suspicious para‐aortic lymph node metastasis in colorectal cancer: A systematic review
    Michelle Zhiyun Chen, Yeng Kwang Tay, Swetha Prabhakaran, Joseph C Kong
    Asia-Pacific Journal of Clinical Oncology.2023; 19(6): 596.     CrossRef
  • Survival benefits of para-aortic lymphadenectomy in colorectal cancer with clinically suspected para-aortic lymph node metastasis: a meta-analysis and systematic review
    Rong-Chang Wang, Jian-Qi Wang, Xiao-Yu Zhou, Chu-lin Zhong, Jin-Xu Chen, Jing-Song Chen
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Influence of Extraperitoneal Metastases on the Curative-Intent Management of Colorectal Peritoneal Metastases
    Frédéric Schell, Amaniel Kefleyesus, Nazim Benzerdjeb, Guillaume Passot, Pascal Rousset, Alhadeedi Omar, Laurent Villeneuve, Julien Péron, Olivier Glehen, Vahan Kepenekian
    Annals of Surgical Oncology.2023; 30(7): 4444.     CrossRef
  • Lymph nodes primary staging of colorectal cancer in 18F-FDG PET/MRI: a systematic review and meta-analysis
    Qingwei Ren, Yanyan Chen, Xuejun Shao, Lanzhong Guo, Xinxin Xu
    European Journal of Medical Research.2023;[Epub]     CrossRef
  • Oncologic Outcomes after Surgical Resection for Para-aortic Lymph Node Metastasis in Colorectal Cancer
    Takayuki Okuno, Masaya Hiyoshi, Yuusuke Kyoden, Junji Yamamoto
    Nippon Daicho Komonbyo Gakkai Zasshi.2023; 76(7): 460.     CrossRef
  • Multicenter study of prognostic factors in paraaortic lymph node dissection for metastatic colorectal cancer
    Jun Woo Bong, Sanghee Kang, Pyoungjae Park
    Annals of Surgical Treatment and Research.2023; 105(5): 271.     CrossRef
  • Outcomes of metachronous para-aortic lymphadenectomy in colorectal cancer: a systematic review of the literature
    Oluwatobi O. Onafowokan, Jennifer Redfern, Agastya Patel, Thomas Satyadas, Minas Baltatzis
    Langenbeck's Archives of Surgery.2023;[Epub]     CrossRef
  • Predictive factors of survival of colorectal cancer patients after para-aortic lymph node metastasis
    Hiroaki Nozawa, Kazushige Kawai, Kazuhito Sasaki, Shigenobu Emoto, Shinya Abe, Hirofumi Sonoda, Koji Murono, Junko Kishikawa, Yuzo Nagai, Yuichiro Yokoyama, Hiroyuki Anzai, Soichiro Ishihara
    International Journal of Clinical Oncology.2022; 27(3): 520.     CrossRef
  • Long-Term Outcomes of Surgical Resection of Pathologically Confirmed Isolated Para-Aortic Lymph Node Metastases in Colorectal Cancer: A Systematic Review
    Maurizio Zizzo, Maria Pia Federica Dorma, Magda Zanelli, Francesca Sanguedolce, Maria Chiara Bassi, Andrea Palicelli, Stefano Ascani, Alessandro Giunta
    Cancers.2022; 14(3): 661.     CrossRef
  • Effect of radical lymphadenectomy in colorectal cancer with para-aortic lymph node metastasis: a systematic review and meta-analysis
    Pengyue Zhao, Xingpeng Yang, Yang Yan, Jiaqi Yang, Songyan Li, Xiaohui Du
    BMC Surgery.2022;[Epub]     CrossRef
  • Prognostic significance of enlarged paraaortic lymph nodes detected during left-sided colorectal cancer surgery: a single-center retrospective cohort study
    Jaram Lee, Hyeong-min Park, Soo Young Lee, Chang Hyun Kim, Hyeong Rok Kim
    World Journal of Surgical Oncology.2021;[Epub]     CrossRef
  • Risk factors for local recurrence and long term survival after minimally invasive intersphincteric resection for very low rectal cancer: Multivariate analysis in 161 patients
    G.N. Piozzi, H. Park, T.H. Lee, J.S. Kim, H.B. Choi, S.J. Baek, J.M. Kwak, J. Kim, S.H. Kim
    European Journal of Surgical Oncology.2021; 47(8): 2069.     CrossRef
  • Effect of lymphadenectomy in colorectal cancer with isolated synchronous para‐aortic lymph node metastasis
    Sung Chul Lee, Hee Cheol Kim, Woo Yong Lee, Seong Hyeon Yun, Yong Beom Cho, Jung Wook Huh, Yoon Ah Park, Jung Kyong Shin
    Colorectal Disease.2021; 23(10): 2584.     CrossRef
  • Robotic Intersphincteric Resection for Low Rectal Cancer: Technical Controversies and a Systematic Review on the Perioperative, Oncological, and Functional Outcomes
    Guglielmo Niccolò Piozzi, Seon Hahn Kim
    Annals of Coloproctology.2021; 37(6): 351.     CrossRef
  • Is 18F-FDG PET/CT an Accurate Way to Detect Lymph Node Metastasis in Colorectal Cancer: A Systematic Review and Meta-Analysis
    Hamid Dahmarde, Fateme Parooie, Morteza Salarzaei
    Contrast Media & Molecular Imaging.2020; 2020: 1.     CrossRef
  • Oncologic outcomes after resection of para-aortic lymph node metastasis in left-sided colon and rectal cancer
    Junichi Sakamoto, Heita Ozawa, Hiroki Nakanishi, Shin Fujita, Norikatsu Miyoshi
    PLOS ONE.2020; 15(11): e0241815.     CrossRef
  • Long-term outcome and prognostic factors for patients with para-aortic lymph node dissection in left-sided colorectal cancer
    Kota Sahara, Jun Watanabe, Atsushi Ishibe, Yusuke Suwa, Hirokazu Suwa, Mitsuyoshi Ota, Chikara Kunisaki, Itaru Endo
    International Journal of Colorectal Disease.2019; 34(6): 1121.     CrossRef
  • 16,177 View
  • 329 Download
  • 25 Web of Science
  • 26 Crossref
Close layer
Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort Study
Se Hyun Kim, Kyung Hae Jung, Tae-Yong Kim, Seock-Ah Im, In Sil Choi, Yee Soo Chae, Sun Kyung Baek, Seok Yun Kang, Sarah Park, In Hae Park, Keun Seok Lee, Yoon Ji Choi, Soohyeon Lee, Joo Hyuk Sohn, Yeon-Hee Park, Young-Hyuck Im, Jin-Hee Ahn, Sung-Bae Kim, Jee Hyun Kim
Cancer Res Treat. 2016;48(4):1373-1381.   Published online March 23, 2016
DOI: https://doi.org/10.4143/crt.2015.475
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Purpose
The purpose of this study is to investigate the prognostic value of lymph node (LN) ratio (LNR) in patients with breast cancer after neoadjuvant chemotherapy.
Materials and Methods
This retrospective analysis is based on the data of 814 patientswith stage II/III breast cancer treated with four cycles of doxorubicin/cyclophosphamide followed by four cycles of docetaxel before surgery. We evaluated the clinical significance of LNR (3 categories: low 0-0.20 vs. intermediate 0.21-0.65 vs. high 0.66-1.00) using a Cox proportional regression model.
Results
A total of 799 patients underwent breast surgery. Pathologic complete response (pCR, ypT0/isN0) was achieved in 129 patients (16.1%) (hormone receptor [HR] +/human epidermal growth factor receptor 2 [HER2] –, 34/373 [9.1%]; HER2+, 45/210 [21.4%]; triple negative breast cancer, 50/216 [23.1%]). The mean numbers of involved LN and retrieved LN were 2.70 (range, 0 to 42) and 13.98 (range, 1 to 64), respectively. The mean LNR was 0.17 (low, 574 [71.8%]; intermediate, 170 [21.3%]; high, 55 [6.9%]). In univariate analysis, LNR showed significant association with a worse relapse-free survival (3-year relapse-free survival rate 84.8% in low vs. 66.2% in intermediate vs. 54.3% in high; p < 0.001, log-rank test). In multivariate analysis, LNR did not show significant association with recurrence after adjusting for other clinical factors (age, histologic grade, subtype, ypT stage, ypN stage, lymphatic or vascular invasion, and pCR). In subgroup analysis, the LNR system had good prognostic value in HR+/HER2– subtype.
Conclusion
LNR is not superior to ypN stage in predicting clinical outcome of breast cancer after neoadjuvant chemotherapy. However, the prognostic value of the LNR system in HR+/HER2– patients is notable and worthy of further investigation.

Citations

Citations to this article as recorded by  
  • Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
    Zhe Wang, Wei Chong, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Zhifang Guo, Li Fu, Yongjie Ma, Feng Gu
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • The prognostic role of lymph node ratio in breast cancer patients received neoadjuvant chemotherapy: A dose-response meta-analysis
    Jinzhao Liu, Yifei Li, Weifang Zhang, Chenhui Yang, Chao Yang, Liang Chen, Mingjian Ding, Liang Zhang, Xiaojun Liu, Guozhong Cui, Yunjiang Liu
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer
    Yul Ri Chung, Ji Won Woo, Soomin Ahn, Eunyoung Kang, Eun-Kyu Kim, Mijung Jang, Sun Mi Kim, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
    Scientific Reports.2021;[Epub]     CrossRef
  • Using a novel T-lymph node ratio model to evaluate the prognosis of nonmetastatic breast cancer patients who received preoperative radiotherapy followed by mastectomy
    Yang Wang, Yuanyuan Zhao, Song Liu, Weifang Tang, Hong Gao, Xucai Zheng, Shikai Hong, Shengying Wang
    Medicine.2017; 96(42): e8203.     CrossRef
  • The genetic variants in the PTEN/PI3K/AKT pathway predict susceptibility and CE(A)F chemotherapy response to breast cancer and clinical outcomes
    Xiang Li, Ruishan Zhang, Zhuangkai Liu, Shuang Li, Hong Xu
    Oncotarget.2017; 8(12): 20252.     CrossRef
  • Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant Chemotherapy
    Ji Hyun Chang, Wan Jeon, Kyubo Kim, Kyung Hwan Shin, Wonshik Han, Dong-Young Noh, Seock-Ah Im, Tae-You Kim, Yung-Jue Bang
    Journal of Breast Cancer.2016; 19(4): 394.     CrossRef
  • 11,718 View
  • 163 Download
  • 7 Web of Science
  • 6 Crossref
Close layer
Correspondences
Close layer
Commentary on “Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors”
Edoardo Virgilio, Francesca Di Gregorio, Genoveffa Balducci
Cancer Res Treat. 2015;47(2):339-340.   Published online February 26, 2015
DOI: https://doi.org/10.4143/crt.2015.038
PDFPubReaderePub

Citations

Citations to this article as recorded by  
  • Benzodiazepines for agitation in patients with delirium
    David Hui
    Current Opinion in Supportive and Palliative Care.2018; 12(4): 489.     CrossRef
  • Reply to Commentary on “Clinical Characteristics and Adequate Treatment of Familial Adenomatous Polyposis Combined with Desmoid Tumors”
    Jin Cheon Kim
    Cancer Research and Treatment.2015; 47(2): 341.     CrossRef
  • 10,722 View
  • 64 Download
  • 2 Web of Science
  • 2 Crossref
Close layer
Case Report
A Unique Case of Erdheim-Chester Disease with Axial Skeleton, Lymph Node, and Bone Marrow Involvement
Jin Lim, Ki Hwan Kim, Koung Jin Suh, Kyung Ah Yoh, Jin Young Moon, Ji Eun Kim, Eun Youn Roh, In Sil Choi, Jin-Soo Kim, Jin Hyun Park
Cancer Res Treat. 2016;48(1):415-421.   Published online February 26, 2015
DOI: https://doi.org/10.4143/crt.2014.160
AbstractAbstract PDFPubReaderePub
Erdheim-Chester disease is a rare non-Langerhans–cell histiocytosis with bone and organ involvement. A 76-year-old man presented with low back pain and a history of visits for exertional dyspnea. We diagnosed him with anemia of chronic disease, cytopenia related to chronic illness, chronic renal failure due to hypertension, and hypothyroidism. However, we could not determine a definite cause or explanation for the cytopenia. Multiple osteosclerotic axial skeleton lesions and axillary lymph node enlargement were detected by computed tomography. Bone marrow biopsy revealed histiocytic infiltration, which was CD68-positive and CD1a-negative. This report describes an unusual presentation of Erdheim-Chester disease involving the bone marrow, axial skeleton, and lymph nodes.

Citations

Citations to this article as recorded by  
  • Erdheim Chester Disease Mimicking Lymphoma: A Case Report
    Philipp Moritz Wunschel, Wolfgang Voss, Marc Keberle
    RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren.2022; 194(03): 310.     CrossRef
  • Myelopathy Secondary to Isolated Thoracic Spine Involvement Mimicking Metastasis in Erdheim–Chester Disease
    Rajesh Rajavelu, Ajoy P. Shetty, Rishi M. Kanna, S Rajasekaran
    Indian Spine Journal.2021; 4(1): 133.     CrossRef
  • Diagnosing a Patient with Erdheim-Chester Disease during the COVID-19 Pandemic
    Georgia Kaiafa, Dimitrios Pilalas, Triantafyllia Koletsa, Stylianos Daios, Georgios Arsos, Adam Hatzidakis, Adonis Protopapas, Kostas Stamatopoulos, Christos Savopoulos
    Medicina.2021; 57(10): 1001.     CrossRef
  • Case of Erdheim–Chester presenting with xanthelasma-like eruption and osteolytic bone lesions: A case report
    Evelyn Alarcon Chinchilla, Marie-Pascale Gourde, Karine Turcotte, Steve Mathieu, Mohamed Amin-Hashem
    SAGE Open Medical Case Reports.2019;[Epub]     CrossRef
  • Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report
    Yeoun Eun Sung, Yoon Seo Lee, Jieun Lee, Kyo Young Lee
    Journal of Pathology and Translational Medicine.2018; 52(3): 183.     CrossRef
  • Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease
    Jaume Monmany, Esther Granell, Laura López, Pere Domingo
    BMJ Case Reports.2018; : bcr-2018-225224.     CrossRef
  • 18F-FDG PET/CT in Erdheim–Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker
    Jason R. Young, Geoffrey B. Johnson, Robert C. Murphy, Ronald S. Go, Stephen M. Broski
    Journal of Nuclear Medicine.2018; 59(5): 774.     CrossRef
  • Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart
    Pengcheng Zhu, Naping Li, Lu Yu, Mariajose Navia Miranda, Guoping Wang, Yaqi Duan
    Cancer Research and Treatment.2017; 49(2): 553.     CrossRef
  • 18,487 View
  • 97 Download
  • 9 Web of Science
  • 8 Crossref
Close layer
Original Articles
Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
Yun-Suhk Suh, Jieun Yu, Byung Chul Kim, Boram Choi, Tae-Su Han, Hye Seong Ahn, Seong-Ho Kong, Hyuk-Joon Lee, Woo Ho Kim, Han-Kwang Yang
Cancer Res Treat. 2015;47(4):718-726.   Published online February 2, 2015
DOI: https://doi.org/10.4143/crt.2014.064
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study is to investigate differentially expressed genes using DNA microarray between advanced gastric cancer (AGC) with aggressive lymph node (LN) metastasis and that with a more advanced tumor stage but without LN metastasis.
Materials and Methods
Five sample pairs of gastric cancer tissue and normal gastric mucosa were taken from three patients with T3N3 stage (highN) and two with T4N0 stage (lowN). Data from triplicate DNA microarray experiments were analyzed, and candidate genes were identified using a volcano plot that showed ≥ 2-fold differential expression and were significant by Welch's t test (p < 0.05) between highN and lowN. Those selected genes were validated independently by reverse- transcriptase–polymerase chain reaction (RT-PCR) using five AGC patients, and tissue- microarray (TMA) comprising 47 AGC patients.
Results
CFTR, LAMC2, SERPINE2, F2R, MMP7, FN1, TIMP1, plasminogen activator inhibitor-1 (PAI- 1), ITGB8, SDS, and TMPRSS4 were commonly up-regulated over 2-fold in highN. REG3A, CD24, ITLN1, and WBP5 were commonly down-regulated over 2-fold in lowN. Among these genes, overexpression of PAI-1 was validated by RT-PCR, and TMA showed 16.7% (7/42) PAI-1 expression in T3N3, but none (0/5) in T4N0 (p=0.393).
Conclusion
DNA microarray analysis and validation by RT-PCR and TMA showed that overexpression of PAI-1 is related to aggressive LN metastasis in AGC.

Citations

Citations to this article as recorded by  
  • Expression of Serpin Family E Member 1 (SERPINE1) Is Associated with Poor Prognosis of Gastric Adenocarcinoma
    Jie Lv, Chunyang Yu, Hanhan Tian, Tao Li, Changhua Yu
    Biomedicines.2023; 11(12): 3346.     CrossRef
  • Helicobacter pylori-induced fibroblast-derived Serpin E1 promotes gastric cancer growth and peritoneal dissemination through p38 MAPK/VEGFA-mediated angiogenesis
    Wei Cheng, Yonghui Liao, Yuan Xie, Qinrong Wang, Leilei Li, Yuanjia Chen, Yan Zhao, Jianjiang Zhou
    Cancer Cell International.2023;[Epub]     CrossRef
  • Analysis of CFTR gene expression as an immunological and prognostic biomarker in pan-cancers
    Qi Wang, Shubing Jia, Jie Zheng, Rongwu Xiang, Yong Cui, Jinghai Zhang, Yijia Xu, Mingyi Zhao
    Computers in Biology and Medicine.2022; 146: 105614.     CrossRef
  • Interplay of Helicobacter pylori, fibroblasts, and cancer cells induces fibroblast activation and serpin E1 expression by cancer cells to promote gastric tumorigenesis
    Xueshu Chen, Wei Chen, Yan Zhao, Qinrong Wang, Wenling Wang, Yining Xiang, Hang Yuan, Yuan Xie, Jianjiang Zhou
    Journal of Translational Medicine.2022;[Epub]     CrossRef
  • SERBP1 affects the apoptotic level by regulating the expression and alternative splicing of cellular and metabolic process genes in HeLa cells
    Junjie Zhou, Wenhao Chen, Qianwen He, Dong Chen, Chunguang Li, Congqing Jiang, Zhao Ding, Qun Qian
    PeerJ.2022; 10: e14084.     CrossRef
  • A qualitative transcriptional signature of recurrence risk for stages II–III gastric cancer patients after surgical resection
    Huarong Zhang, Xiangyu Li, Junling Wu, Jiahui Zhang, Haiyan Huang, Yawei Li, Meifeng Li, Shanshan Wang, Jie Xia, Lishuang Qi, Ting Chen, Lu Ao
    Journal of Gastroenterology and Hepatology.2021; 36(9): 2501.     CrossRef
  • Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer
    Qiaoyun Zhao, Jun Xie, Jinliang Xie, Rulin Zhao, Conghua Song, Huan Wang, Jianfang Rong, Lili Yan, Yanping Song, Fangfei Wang, Yong Xie
    Cancer Biomarkers.2021; 31(1): 59.     CrossRef
  • Current therapeutic options for gastric adenocarcinoma
    C.R. Akshatha, Smitha Bhat, R. Sindhu, Dharini Shashank, Sarana Rose Sommano, Wanaporn Tapingkae, Ratchadawan Cheewangkoon, Shashanka K. Prasad
    Saudi Journal of Biological Sciences.2021; 28(9): 5371.     CrossRef
  • Experimental and Clinical Evidence Supports the Use of Urokinase Plasminogen Activation System Components as Clinically Relevant Biomarkers in Gastroesophageal Adenocarcinoma
    Gary Tincknell, Ann-Katrin Piper, Morteza Aghmesheh, Therese Becker, Kara Lea Vine, Daniel Brungs, Marie Ranson
    Cancers.2021; 13(16): 4097.     CrossRef
  • Sustained postoperative plasma elevations of plasminogen activator inhibitor‑1 following minimally invasive colorectal cancer resection
    H.M.C. Kumara, Addison Poppy, Dasuni Gamage, Erica Pettke, Abhinit Shah, Xiaohong Yan, Vesna Cekic, Richard Whelan
    Molecular and Clinical Oncology.2021;[Epub]     CrossRef
  • High WBP5 expression correlates with elevation of HOX genes levels and is associated with inferior survival in patients with acute myeloid leukaemia
    C. Ward, P. Cauchy, P. Garcia, J. Frampton, M. A. Esteban, G. Volpe
    Scientific Reports.2020;[Epub]     CrossRef
  • microRNA‐501‐5p promotes cell proliferation and migration in gastric cancer by downregulating LPAR1
    Xiang Ma, Jiaxi Feng, Ming Lu, Wenjuan Tang, Jianbo Han, XiaGang Luo, Qinghong Zhao, Li Yang
    Journal of Cellular Biochemistry.2020; 121(2): 1911.     CrossRef
  • Adipocyte-Derived Leptin Promotes PAI-1-Mediated Breast Cancer Metastasis in a STAT3/miR-34a Dependent Manner
    Si-Jing Li, Xiao-Hui Wei, Xiao-Man Zhan, Jin-Yong He, Yu-Qi Zeng, Xue-Mei Tian, Sheng-Tao Yuan, Li Sun
    Cancers.2020; 12(12): 3864.     CrossRef
  • Global transcriptomic analysis identifiesSERPINE1as a prognostic biomarker associated with epithelial-to-mesenchymal transition in gastric cancer
    Bodong Xu, Zhigang Bai, Jie Yin, Zhongtao Zhang
    PeerJ.2019; 7: e7091.     CrossRef
  • Role of ion channels in gastrointestinal cancer
    Kyle J Anderson, Robert T Cormier, Patricia M Scott
    World Journal of Gastroenterology.2019; 25(38): 5732.     CrossRef
  • Clinicopathological and Prognostic Significance of WW Domain Binding Protein 5 Expression in Papillary Thyroid Carcinoma
    Yangyang Qian, Zongfu Pan, Zhenying Guo, Xinyang Ge, Guowan Zheng, Jun Cao, Ping Huang, Xin Zhu, Xuhang Zhu, Qingliang Wen, Minghua Ge
    BioMed Research International.2019; 2019: 1.     CrossRef
  • Cystic fibrosis transmembrane conductance regulator—emerging regulator of cancer
    Jieting Zhang, Yan Wang, Xiaohua Jiang, Hsiao Chang Chan
    Cellular and Molecular Life Sciences.2018; 75(10): 1737.     CrossRef
  • Identification of Potential Key Genes Associated With the Pathogenesis and Prognosis of Gastric Cancer Based on Integrated Bioinformatics Analysis
    Xinkui Liu, Jiarui Wu, Dan Zhang, Zhitong Bing, Jinhui Tian, Mengwei Ni, Xiaomeng Zhang, Ziqi Meng, Shuyu Liu
    Frontiers in Genetics.2018;[Epub]     CrossRef
  • The Expression and Significance of FAK/PI3K/AKt/mTOR Signaling Pathway Related Proteins in Human Gastric Carcinoma
    波 于
    World Journal of Cancer Research.2018; 08(03): 113.     CrossRef
  • Proteomic analysis of evodiamine-induced cytotoxicity in thyroid cancer cells
    Hui-I Yu, Hsiu-Chuan Chou, Yi-Ching Su, Li-Hsun Lin, Chieh-Hsiang Lu, Hsiang-Hsun Chuang, Yi-Ting Tsai, En-Chi Liao, Yu-Shan Wei, Yi-Ting Yang, Ying-Ray Lee, Hong-Lin Chan
    Journal of Pharmaceutical and Biomedical Analysis.2018; 160: 344.     CrossRef
  • Dynamic matrisome: ECM remodeling factors licensing cancer progression and metastasis
    Arseniy E. Yuzhalin, Su Yin Lim, Anton G. Kutikhin, Alex N. Gordon-Weeks
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2018; 1870(2): 207.     CrossRef
  • MicroRNA-200c binding to FN1 suppresses the proliferation, migration and invasion of gastric cancer cells
    Hengchun Zhang, Zhiguo Sun, Yan Li, Dong Fan, Hao Jiang
    Biomedicine & Pharmacotherapy.2017; 88: 285.     CrossRef
  • Methylation Levels of LINE-1 As a Useful Marker for Venous Invasion in Both FFPE and Frozen Tumor Tissues of Gastric Cancer
    Jimin Min, Boram Choi, Tae-Su Han, Hyuk-Joon Lee, Seong-Ho Kong, Yun-Suhk Suh, Tae-Han Kim, Hwi-Nyeong Choe, Woo Ho Kim, Keun Hur, Han-Kwang Yang
    Molecules and Cells.2017; 40(5): 346.     CrossRef
  • WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway
    Ruixiang Tang, Yingying Lei, Bingshuang Hu, Jie Yang, Shun Fang, Qiongyao Wang, Man Li, Linlang Guo
    British Journal of Cancer.2016; 115(2): 243.     CrossRef
  • Gastric cancer from operating theatre to bench in Korea
    H-K Yang
    British Journal of Surgery.2016; 103(10): 1251.     CrossRef
  • The embryonic stress response to in vitro culture: insight from genomic analysis
    Gael Cagnone, Marc-André Sirard
    Reproduction.2016; 152(6): R247.     CrossRef
  • 15,373 View
  • 163 Download
  • 27 Web of Science
  • 26 Crossref
Close layer
Using the Lymph Node Ratio to Evaluate the Prognosis of Stage II/III Breast Cancer Patients Who Received Neoadjuvant Chemotherapy and Mastectomy
San-Gang Wu, Qun Li, Juan Zhou, Jia-Yuan Sun, Feng-Yan Li, Qin Lin, Huan-Xin Lin, Xun-Xing Gaun, Zhen-Yu He
Cancer Res Treat. 2015;47(4):757-764.   Published online December 8, 2014
DOI: https://doi.org/10.4143/crt.2014.039
AbstractAbstract PDFPubReaderePub
Purpose
This study was conducted to investigate the prognostic value of lymph node ratio (LNR) in stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.
Materials and Methods
Clinical and pathological data describing stage II/III breast cancer patients were included in this retrospective study. The primary outcomes were locoregional recurrence-free survival (LRFS), distant metastasis-free survival (DMFS), disease-free survival (DFS), and overall survival (OS).
Results
Among 277 patients, there were 43 ypN0, 64 ypN1, 89 ypN2, and 81 ypN3 cases. Additionally, there were 43, 57, 92 and 85 cases in the LNR 0, 0.01-0.20, 0.21-0.65, and > 0.65 groups, respectively. The median follow-up was 49.5 months. Univariate analysis showed that both ypN stage and LNR were prognostic factors of LRFS, DMFS, DFS, and OS (p < 0.05). Multivariate analysis showed that LNR was an independent prognostic factor of LRFS, DMFS, DFS, and OS (p < 0.05), while ypN stage had no effect on prognosis (p > 0.05).
Conclusion
The integrated use of LNR and ypN may be suitable for evaluation the prognosis of stage II/III breast cancer patients who undergo mastectomy after neoadjuvant chemotherapy.

Citations

Citations to this article as recorded by  
  • Prognosis and influencing factors of ER-positive, HER2-low breast cancer patients with residual disease after neoadjuvant chemotherapy: a retrospective study
    Lingfeng Tang, Linshan Jiang, Xiujie Shu, Yudi Jin, Haochen Yu, Shengchun Liu
    Scientific Reports.2024;[Epub]     CrossRef
  • Prognostic disparities in young patients based on breast cancer subtype: A population-based study from the SEER database
    Bing Chen, Xiaojuan Zhang, Yi Liu, Chuandong Wang
    Medicine.2023; 102(13): e33416.     CrossRef
  • The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy
    Zhuangbin Lin, Xiaobo Li, Jianyuan Song, Rong Zheng, Cheng Chen, Anchuan Li, Benhua Xu
    Frontiers in Oncology.2022;[Epub]     CrossRef
  • Breast Cancer Patients With Positive Apical or Infraclavicular/Ipsilateral Supraclavicular Lymph Nodes Should Be Excluded in the Application of the Lymph Node Ratio System
    Zhe Wang, Wei Chong, Huikun Zhang, Xiaoli Liu, Yawen Zhao, Zhifang Guo, Li Fu, Yongjie Ma, Feng Gu
    Frontiers in Cell and Developmental Biology.2022;[Epub]     CrossRef
  • Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
    Hee Jun Choi, Jai Min Ryu, Jun Ho Lee, Yoonju Bang, Jongwook Oh, Byung-Joo Chae, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Se Kyung Lee, Jonghan Yu
    Journal of Clinical Medicine.2022; 11(21): 6564.     CrossRef
  • A novel nomogram for predicting locoregional recurrence risk in breast cancer patients treated with neoadjuvant chemotherapy and mastectomy
    Zhou Huang, Mei Shi, Wei-Hu Wang, Liang-Fang Shen, Yu Tang, Qing-Lin Rong, Li Zhu, Xiao-Bo Huang, Jian Tie, Jia-Yi Chen, Jun Zhang, Hong-Fen Wu, Jing Cheng, Min Liu, Chang-Ying Ma, Shu-Lian Wang, Ye-Xiong Li
    Radiotherapy and Oncology.2021; 161: 191.     CrossRef
  • Lymph node ratio as best prognostic factor in triple‐negative breast cancer patients with residual disease after neoadjuvant chemotherapy
    Gabriel A. De la Cruz‐Ku, Diego Chambergo‐Michilot, Bryan Valcarcel, Pamela Rebaza, Mecker Möller, Jhajaira M. Araujo, Daniel Enriquez, Zaida Morante, Cesar Razuri, Renato Luque, Antonella Saavedra, Eduardo Eyzaguirre, Maria Lujan, Naysha Noel, Joseph Pin
    The Breast Journal.2020; 26(9): 1659.     CrossRef
  • Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy
    Jianguo Lai, Zihao Pan, Peixian Chen, Guolin Ye, Kai Chen, Fengxi Su
    Japanese Journal of Clinical Oncology.2019; 49(1): 22.     CrossRef
  • Lymph node ratio as an alternative to pN staging for predicting prognosis after neoadjuvant chemotherapy in breast cancer
    Dong Hui Cho, Soo Youn Bae, Ji Young You, Hong Kyu Kim, Young Woo Chang, Yoo Jin Choi, Sang Uk Woo, Gil Soo Son, Jae Bok Lee, Jeoung Won Bae, Seung Pil Jung
    The Kaohsiung Journal of Medical Sciences.2018; 34(6): 341.     CrossRef
  • Ganglio secundario como indicador de linfadenectomía axilar en pacientes afectas de cáncer de mama
    Manel Cremades, Mireia Torres, Montse Solà, Jordi Navinés, Icíar Pascual, Antonio Mariscal, Albert Caballero, Eva Castellà, Miguel Ángel Luna, Joan Francesc Julián
    Cirugía Española.2017; 95(9): 536.     CrossRef
  • Secondary Node Analysis as an Indicator for Axillary Lymphadenectomy in Breast Cancer Patients
    Manel Cremades, Mireia Torres, Montse Solà, Jordi Navinés, Icíar Pascual, Antonio Mariscal, Albert Caballero, Eva Castellà, Miguel Ángel Luna, Joan Francesc Julián
    Cirugía Española (English Edition).2017; 95(9): 536.     CrossRef
  • Risk factors of locoregional relapse in locally advanced breast cancer treated with neoadjuvant chemotherapy following mastectomy and radiotherapy
    Liang Huang, Sheng Chen, Wentao T. Yang, Zhiming Shao
    Oncotarget.2017; 8(24): 39703.     CrossRef
  • Lymph Node Ratio Analysis After Neoadjuvant Chemotherapy is Prognostic in Hormone Receptor-Positive and Triple-Negative Breast Cancer
    Jacqueline Tsai, Danielle Bertoni, Tina Hernandez-Boussard, Melinda L. Telli, Irene L. Wapnir
    Annals of Surgical Oncology.2016; 23(10): 3310.     CrossRef
  • Number of negative lymph nodes as a prognostic factor for ypN0-N1 breast cancer patients undergoing neoadjuvant chemotherapy
    Fei Xin, Yue Yu, Zheng-Jun Yang, Li-Kun Hou, Jie-Fei Mao, Li Xia, Xin Wang, Xu-Chen Cao
    Tumor Biology.2016; 37(6): 8445.     CrossRef
  • 11,889 View
  • 86 Download
  • 18 Web of Science
  • 14 Crossref
Close layer
A Distribution Weighted Prognostic Scoring Model for Node Status in Advanced Rectal Cancer
Kwang-Hee Yeo, Ho Hyun Kim, Dong-Yi Kim, Young-Jin Kim, Jae-Kyun Ju
Cancer Res Treat. 2014;46(1):41-47.   Published online January 15, 2014
DOI: https://doi.org/10.4143/crt.2014.46.1.41
AbstractAbstract PDFPubReaderePub
PURPOSE
There are various lymph node-based staging systems. Nevertheless, there is debate over the use of parameters such as the number of involved lymph nodes and the lymph node ratio. As a possible option, the distribution of metastatic lymph nodes may have a prognostic significance in rectal cancer. This study is designed to evaluate the impact of distribution-weighted nodal staging on oncologic outcome in rectal cancer.
MATERIALS AND METHODS
From a prospectively maintained colorectal cancer database of our institution, a total of 435 patients who underwent a curative low anterior resection for mid and upper rectal cancer between 1995 and 2004 were enrolled. Patients were divided into 3 groups according to the location of apical metastatic nodes. A location-weighted prognostic score was calculated by a scoring model using a logistic regression test for location based-statistical weight to number of lymph nodes. All cases were categorized in quartiles from lymph node I to lymph node IV using this protocol.
RESULTS
The location of lymph node metastasis was an independent factor that was associated with a poor prognostic outcome (p<0.001). Based on this result, the location-weighted-nodal prognostic scoring model did not show lesser significant results (p<0.0001) in both overall survival and cancer-free survival analyses.
CONCLUSION
The location of apical nodes among the metastatic nodes does not have a lesser significant impact on oncologic result in patients with advanced rectal cancer. A location-weighted prognostic scoring model, which considered the numbers of involved lymph nodes as the rate of significance according to the location, may more precisely predict the survival outcome in patients with lymph node metastasis.

Citations

Citations to this article as recorded by  
  • Prognostic factors for T1-2 colorectal cancer after radical resection: Lymph node distribution is a valuable predictor of its survival
    Xing Huang, Hao Liu, Xiangqi Liao, Zhigang Xiao, Zhongcheng Huang, Guoxin Li
    Asian Journal of Surgery.2021; 44(1): 241.     CrossRef
  • Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation
    Hongmei Zhang, Chongda Zhang, Zhaoxu Zheng, Feng Ye, Yuan Liu, Shuangmei Zou, Chunwu Zhou
    European Radiology.2017; 27(9): 3845.     CrossRef
  • Prognostic impact of lymph node skip metastasis in Stage III colorectal cancer
    F. Bao, L.‐y. Zhao, A. I. Balde, H. Liu, J. Yan, T.‐t. Li, H. Chen, G.‐x. Li
    Colorectal Disease.2016;[Epub]     CrossRef
  • Prognostic Impact of Distribution of Lymph Node Metastases in Stage III Colon Cancer
    Toshiya Nagasaki, Takashi Akiyoshi, Yoshiya Fujimoto, Tsuyoshi Konishi, Satoshi Nagayama, Yosuke Fukunaga, Masami Arai, Masashi Ueno
    World Journal of Surgery.2015; 39(12): 3008.     CrossRef
  • Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience
    Eyad Fawzi AlSaeed, Mutahir Tunio, Ahmad Zubaidi, Omar Al-Obaid, Abdullah Kamal Ahmed, Omar Abdulmohsen Al-Omar, Emad Ahmed Abid, Mohammed Jaber Alsiwat
    Annals of Saudi Medicine.2015; 35(1): 23.     CrossRef
  • 10,481 View
  • 52 Download
  • 5 Web of Science
  • 5 Crossref
Close layer
Case Reports
Poorly Differentiated Neuroendocrine Carcinoma in a Perigastric Lymph Node from an Unknown Primary Site
Hee Seung Lee, Hye-Suk Han, Sung-Nam Lim, Hyun-Jung Jeon, Ho-chang Lee, Ok-Jun Lee, Hyo Young Yun, Ki Hyeong Lee, Seung Taik Kim
Cancer Res Treat. 2012;44(4):271-274.   Published online December 31, 2012
DOI: https://doi.org/10.4143/crt.2012.44.4.271
AbstractAbstract PDFPubReaderePub
Neuroendocrine carcinomas from an unknown primary site are uncommon. The authors report on a case of neuroendocrine carcinoma in a perigastric lymph node (LN) with no primary site. A 52-year-old male patient with early gastric adenocarcinoma underwent treatment by endoscopic submucosal dissection, and, six months later, findings on a computed tomographic scan of the abdomen revealed a LN enlargement measuring 2.0 cm in the perigastric region. The patient underwent subtotal gastrectomy and regional LN dissection under a suggestive preoperative diagnosis of gastric adenocarcinoma with LN metastasis. However, microscopically, no residual tumor was found in the stomach, and the perigastric LN showed poorly differentiated neuroendocrine carcinoma (PDNEC). After an extensive workup, no primary site was identified. The patient also received four cycles of etoposide and cisplatin. Despite its extremely rare incidence, this case suggests that PDNEC of an unknown primary site is limited to a single site, and that resection should be considered in combination with chemotherapy.

Citations

Citations to this article as recorded by  
  • A case of laparoscopic lymphadenectomy for adenocarcinoma of unknown primary incidentally detected as a solitary enlarged lymph node along the common hepatic artery
    Tomonori Morimoto, Shigeo Hisamori, Hiromitsu Kinoshita, Yosuke Yamada, Yuki Teramoto, Takashi Sakamoto, Keiko Kasahara, Shintaro Okumura, Tatsuto Nishigori, Shigeru Tsunoda, Kazutaka Obama
    Surgical Case Reports.2024;[Epub]     CrossRef
  • Synchronous Gastric Adenocarcinoma and Perigastric Lymph Node Metastatic Squamous Cell Carcinoma with Unknown Primary: A Case Report
    Bernard K Seshie, Ki Hyun Kim, Hyun Jung Lee, Si Hak Lee, Sun-Hwi Hwang
    The Journal of Minimally Invasive Surgery.2020; 23(2): 99.     CrossRef
  • Metastatic Neuroendocrine Carcinoma of Unknown Origin Arising in the Femoral Nerve Sheath
    Nicholas Candy, Adam Young, Kieren Allinson, Oliver Carr, Jason McMillen, Rikin Trivedi
    World Neurosurgery.2017; 104: 1047.e1.     CrossRef
  • Submucosal small-cell neuroendocrine carcinoma of the larynx detected using 18F-fluorodeoxyglucose positron emission tomography/computed tomography: A case report and review of the literature
    HONG-FANG YING, YANG-YANG BAO, SHUI-HONG ZHOU, LIANG CHAI, KUI ZHAO, TING-TING WU
    Oncology Letters.2014; 8(3): 1065.     CrossRef
  • 11,198 View
  • 49 Download
  • 4 Crossref
Close layer
Metastatic Renal Cell Carcinoma in a Supraclavicular Lymph Node with No Known Primary: A Case Report
Young-Rak Choi, Hye-Suk Han, Ok-Jun Lee, Sung-Nam Lim, Mi-Jin Kim, Myeong-Ho Yeon, Hyun-Jung Jeon, Ki Hyeong Lee, Seung Taik Kim
Cancer Res Treat. 2012;44(3):215-218.   Published online September 30, 2012
DOI: https://doi.org/10.4143/crt.2012.44.3.215
AbstractAbstract PDFPubReaderePub
Although metastasis is relatively frequent in cases of renal cell carcinoma (RCC), metastasis in the cervical or supraclavicular lymph node (LN) is relatively rare. Moreover, cases of metastatic RCC with a non-identifiable kidney mass are extremely rare. Here, the authors report a case of metastatic RCC in a supraclavicular LN without a primary kidney lesion. A 69-year-old man presented with a progressively enlarging right supraclavicular mass. Incisional biopsy of the affected supraclavicular LN was performed, and histological examination revealed metastatic RCC. However, no tumor was found in either kidney, despite various examinations. The patient was treated with radiotherapy followed by sunitinib. After three months on sunitinib, a follow-up computed tomography scan revealed that the supraclavicular LN had markedly decreased, and after 20 months, the disease had not progressed. This case suggests that, even when there is no primary kidney lesion, clinicians must consider the possibility of metastatic RCC when evaluating patients with clear cell carcinoma with an unknown primary site.

Citations

Citations to this article as recorded by  
  • Pure Metastatic Papillary Renal Cell Carcinoma Without Renal Mass: A Case Report and Literature Review
    Pay Enes, Ibrahim Hacibey, Serhat Yentur, Salih Sonmez, Atilla Semercioz
    International Journal of Clinical and Experimental Medical Sciences.2024; 10(2): 25.     CrossRef
  • Nivolumab rechallenge after severe immune hepatitis in a metastatic renal cell cancer patient with hepatitis B and no detectable primary
    Lutfiye Demir, Funda Canaz
    Indian Journal of Cancer.2023; 60(1): 114.     CrossRef
  • Extrarenal renal cell carcinoma arising in the kidney proximity but without an identifiable renal primary – an intriguing dilemma: report of three cases and review of the literature
    Mehdi Mansoor, Morgan Young‐Speirs, Bing Ren, Geoffrey Gotto, Larissa Merten, Summit Sawhney, Farshid Siadat, Andres M Acosta, Abbas Agaimy, Kiril Trpkov
    Histopathology.2022; 81(5): 635.     CrossRef
  • New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
    Elie Rassy, Pauline Parent, Felix Lefort, Stergios Boussios, Giulia Baciarello, Nicholas Pavlidis
    Critical Reviews in Oncology/Hematology.2020; 147: 102882.     CrossRef
  • Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
    N. A. Ognerubov, T. S. Antipova, G. E. Gumareva
    Journal of Modern Oncology.2020; 22(3): 149.     CrossRef
  • Carcinoma of Unknown Primary Site (CUP) With Metastatic Renal-Cell Carcinoma (mRCC) Histologic and Immunohistochemical Characteristics (CUP-mRCC): Results From Consecutive Patients Treated With Targeted Therapy and Review of Literature
    Anders Overby, Lone Duval, Morten Ladekarl, Britt Elmedal Laursen, Frede Donskov
    Clinical Genitourinary Cancer.2019; 17(1): e32.     CrossRef
  • Central pancreatectomy in portal annular pancreas for metastatic renal cell carcinoma: a case report
    Hiroshi Yamaguchi, Yasutoshi Kimura, Minoru Nagayama, Masafumi Imamura, Shingo Tanaka, Makoto Yoshida, Eiji Yoshida, Hiroki Fujino, Takashi Machiki, Koji Miyanishi, Toru Mizuguchi, Junji Kato, Ichiro Takemasa
    World Journal of Surgical Oncology.2019;[Epub]     CrossRef
  • Metastatic renal cell carcinoma with undetectable renal mass presenting as lymphadenopathy
    Mohamed Salah Fayaz, Aishah Ebrahim Al-Qaderi, Mustafa Shawki El-Sherify
    CEN Case Reports.2017; 6(1): 36.     CrossRef
  • The clinical application of angiostatic therapy in combination with radiotherapy: past, present, future
    Lisanne C. Hamming, Ben J. Slotman, Henk M. W. Verheul, Victor L. Thijssen
    Angiogenesis.2017; 20(2): 217.     CrossRef
  • Optimal treatment scheduling of ionizing radiation and sunitinib improves the antitumor activity and allows dose reduction
    Esther A. Kleibeuker, Matthijs A. ten Hooven, Kitty C. Castricum, Richard Honeywell, Arjan W. Griffioen, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen
    Cancer Medicine.2015; 4(7): 1003.     CrossRef
  • Combining radiotherapy with sunitinib: lessons (to be) learned
    Esther A. Kleibeuker, Matthijs A. ten Hooven, Henk M. Verheul, Ben J. Slotman, Victor L. Thijssen
    Angiogenesis.2015; 18(4): 385.     CrossRef
  • Sunitinib

    Reactions Weekly.2014; 1494(1): 42.     CrossRef
  • To combine or not combine: the role of radiotherapy and targeted agents in the treatment for renal cell carcinoma
    Christian Weiss, Björn Schulze, Annette Ottinger, Claus Rödel
    World Journal of Urology.2014; 32(1): 59.     CrossRef
  • 13,007 View
  • 99 Download
  • 13 Crossref
Close layer
Follicular Dendritic Cell Sarcoma: A Case Report and Review of the Literature
Bo Sik Choi, Jin Ho Baek, Young Min Shin, Jong Hyung Kim, Hyung Wook Kim, Soon Jung Lee, Hee Jeong Cha
Cancer Res Treat. 2010;42(2):121-124.   Published online June 30, 2010
DOI: https://doi.org/10.4143/crt.2010.42.2.121
AbstractAbstract PDFPubReaderePub

Follicular dendritic cells (FDC) are non-lymphoid, non-phagocytic accessory cells of the immune system and these cells are essential for antigen presentation and regulation of the reactions in germinal centers. Follicular dendritic cell sarcoma (FDCS) is a rare neoplasm that shows a low-to-intermediate malignant potential. The most commonly involved sites are the lymph nodes, but FDCS may also occur at a variety of extranodal sites, including the oral cavity, tonsils, gastrointestinal tract and liver. We describe here a 79-year-old woman who had FDCS with extensive lymph node involvement, dry cough, and an itching sensation. The patient improved after systemic chemotherapy.

Citations

Citations to this article as recorded by  
  • Pancreatic follicular dendritic cell sarcoma: a case report
    Jing Lou, Runyu Xia, Guoli Li, Jun Su, Hong Zheng
    World Journal of Surgical Oncology.2023;[Epub]     CrossRef
  • Pancreatic follicular dendritic cell sarcoma: one case report and literature review
    Xiangyu Lu, Yilei Wu, Jun Gong, Xiaojiong Yu, Yu Zhang, Chong Yang
    Journal of International Medical Research.2022;[Epub]     CrossRef
  • Death within 9 months in patient with follicular dendritic cell sarcoma of spleen: A case report
    Zhao-Yang Xing
    Oncology Letters.2022;[Epub]     CrossRef
  • Nodal follicular dendritic cell sarcoma of the axilla with brachial plexus palsy
    Aftab Younus, Adrian Kelly, Patrick Lekgwara
    Interdisciplinary Neurosurgery.2020; 19: 100557.     CrossRef
  • Intra-abdominal Follicular Dendritic Cell Sarcoma (FDCS): Series of 18 cases of a rare entity from Pakistan
    Maha Zubair, Nasir Ud Din, Sidra Arshad, Khurram Minhas, Romana Idress, Zubair Ahmad
    Annals of Diagnostic Pathology.2020; 49: 151595.     CrossRef
  • Follicular dendritic cell sarcoma treated with a variety of chemotherapy
    Masaoki Sasaki, Hiroaki Izumi, Takaaki Yokoyama, Motohiro Kojima, Ako Hosono
    Hematological Oncology.2017; 35(4): 905.     CrossRef
  • High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model
    Tasuku Kiyuna, Takashi Murakami, Yasunori Tome, Kei Kawaguchi, Kentaro Igarashi, Yong Zhang, Ming Zhao, Yunfeng Li, Michael Bouvet, Fuminori Kanaya, Arun Singh, Sarah Dry, Fritz C. Eilber, Robert M. Hoffman
    Oncotarget.2016; 7(22): 33046.     CrossRef
  • Follicular dendritic cell sarcoma with extensive lymph node involvement: A case report
    LI GU, CHUNHUI OUYANG, FANGGEN LU
    Oncology Letters.2015; 10(1): 399.     CrossRef
  • Clinical and pathological features of head and neck follicular dendritic cell sarcoma
    Ji Li, Min-Li Zhou, Shui-Hong Zhou
    Hematology.2015; 20(10): 571.     CrossRef
  • Follicular Dendritic Cell Sarcoma of the Tonsil
    Leandro Ribeiro, Nuno Lima, António Almeida, Artur Condé
    Acta Otorrinolaringologica (English Edition).2014; 65(3): 200.     CrossRef
  • Sarcoma de células foliculares dendríticas de la amígdala
    Leandro Ribeiro, Nuno Lima, António Almeida, Artur Condé
    Acta Otorrinolaringológica Española.2014; 65(3): 200.     CrossRef
  • Follicular Dendritic Cell Sarcoma of the Peripancreatic Lymph Node
    Minori ISHII, Minoru TAKADA, Hiroko NOGUCHI, Tomoko MITSUHASHI, Fumitaka NAKAMURA, Nobuichi KASHIMURA
    Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association).2014; 75(11): 3147.     CrossRef
  • Dendritic cell sarcoma: A pooled analysis including 462 cases with presentation of our case series
    Caner Saygin, Didem Uzunaslan, Mustafa Ozguroglu, Mustafa Senocak, Nukhet Tuzuner
    Critical Reviews in Oncology/Hematology.2013; 88(2): 253.     CrossRef
  • Paraneoplastic pemphigus associated with dendritic cell neoplasm and Castleman’s disease: report of a new case and review of the literature
    Bernardino Roca, Gerard Pitarch, Francisco Soler, Maria Penades, Elena Resino, Manuel Roca
    Open Medicine.2013; 8(2): 153.     CrossRef
  • Dendritic cell tumor in a salivary gland lymph node: a rare differential diagnosis of salivary gland neoplasms
    Sebastian P Schraven, Stefan K Plontke, Roland Syha, Falko Fend, Hartwig Wolburg, Patrick Adam
    Diagnostic Pathology.2011;[Epub]     CrossRef
  • Cervical Follicular Dendritic Cell Sarcoma: A Case Report and Review of the Literature
    M. Pizzi, K. Ludwig, G. Palazzolo, G. Busatto, C. Rettore, G. Altavilla
    International Journal of Immunopathology and Pharmacology.2011; 24(2): 539.     CrossRef
  • 11,413 View
  • 93 Download
  • 16 Crossref
Close layer
M llerian-Type Gland Inclusions in Pelvic Lymph Nodes Mimicking Metastasis: A Case Report and Review of the Literature
Jinyoung Yoo, Hyun Joo Choi, Seok Jin Kang
Cancer Res Treat. 2003;35(2):165-167.   Published online April 30, 2003
DOI: https://doi.org/10.4143/crt.2003.35.2.165
AbstractAbstract PDF
Benign lymph node inclusions are rare, and can be mistaken for metastasis. We report, herein, a case of a 50-year-old woman who underwent a hysterectomy, with a lymphadenectomy, for an endometrial carcinoma. There was no lymph node metastasis; however, the left external and common iliac lymph nodes demonstrated a few glands, consistent with M llerian-type inclusions (endosalpingiosis). Awareness of these lesions is important to avoid either unnecessary therapy or any delay in treatment. Furthermore, pelvic and aortic lymphadenectomies may be warranted, as neoplastic transformation of preexisting metaplastic tubal-type epithelium is strongly suggested. This paper presents a case of intranodal endosalpingiosis mimicking metastasis.

Citations

Citations to this article as recorded by  
  • Intraoperative Appearance of Endosalpingiosis: A Single-Center Experience of Laparoscopic Findings and Systematic Review of Literature
    Laurin Burla, Dimitrios Rafail Kalaitzopoulos, Anna Mrozek, Markus Eberhard, Nicolas Samartzis
    Journal of Clinical Medicine.2022; 11(23): 7006.     CrossRef
  • Endosalpingiose – ein irrelevanter laparoskopischer Zufallsbefund?
    Laurin Burla, Dimitrios Rafail Kalaitzopoulos, Markus Eberhard, Nicolas Samartzis
    Praxis.2021; 110(14): 804.     CrossRef
  • Primary lesions that may imitate metastatic tumors histologically: A selective review
    Mark R. Wick
    Seminars in Diagnostic Pathology.2018; 35(2): 123.     CrossRef
  • 3,501 View
  • 26 Download
  • 3 Crossref
Close layer
Original Article
Hodgkin's Disease of the High Cervical Lymph Nodes
Jong Ouck Choi, Yong Whoan Kim, Chan Park, Kwang Yoon Jung, Gun Choi
J Korean Cancer Assoc. 1996;28(5):881-888.
AbstractAbstract PDF
Hodgkin's disease is a lymphoreticular malignancy that usually presents as painless lymphadenopathy, frequently in the cervical area. The most frequently palpable lymph nodes of the Hodgkin's disease at presentation are in the lower cervical and supraclavicular areas. Lymphadenopathy of high cervical nodes are commonly diagnosed as reactive lymphadenopathy rather than the Hodgkin's disease which may cause a delay in making a correct diagnosis of Hodgkin's lymphoma. Here we report 3 cases which were admitted with the chief complaint of high cervical mass. They were initially misdiagnosed as nonspecific lymphadenitis and were treated with antibiotics for a few weeks without improvement. Therefore, we performed excisional biopsy of palpable nodes to confirm to diagnose the Hodgkin's disease. The patients were treated with radiotherapy or chemoradiotherapy according to Ann Arbor staging. In our experience, excisional biopsy is preferred in cases of high cervical lymph nodes greater than 3 cm in diameter which are not accurately diagnosed with fine needle aspiration biopsy and are not responsive to antibiotics for a few weeks.
  • 2,355 View
  • 12 Download
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP